ANGIOPLASTY, VARIOUS TECHNIQUES AND CHALLENGES IN TREATMENT OF CONGENITAL AND ACQUIRED VASCULAR STENOSES doc

ANGIOPLASTY, VARIOUS
TECHNIQUES AND
CHALLENGES IN
TREATMENT OF
CONGENITAL AND
ACQUIRED VASCULAR
STENOSES

Edited by Thomas Forbes
ȱ
ȱȱ
ȱ
ȱ
ȱ
ȱ
ȱ
ȱ
ȱ
Angioplasty, Various Techniques and Challenges in Treatment of Congenital and
Acquired Vascular Stenoses
Edited by Thomas Forbes


Published by InTech
Janeza Trdine 9, 51000 Rijeka, Croatia

Copyright © 2012 InTech
All chapters are Open Access distributed under the Creative Commons Attribution 3.0
license, which allows users to download, copy and build upon published articles even for
commercial purposes, as long as the author and publisher are properly credited, which

ensures maximum dissemination and a wider impact of our publications. After this work
has been published by InTech, authors have the right to republish it, in whole or part, in
any publication of which they are the author, and to make other personal use of the
work. Any republication, referencing or personal use of the work must explicitly identify
the original source.

As for readers, this license allows users to download, copy and build upon published
chapters even for commercial purposes, as long as the author and publisher are properly
credited, which ensures maximum dissemination and a wider impact of our publications.

Notice
Statements and opinions expressed in the chapters are these of the individual contributors
and not necessarily those of the editors or publisher. No responsibility is accepted for the
accuracy of information contained in the published chapters. The publisher assumes no
responsibility for any damage or injury to persons or property arising out of the use of any
materials, instructions, methods or ideas contained in the book.

Publishing Process Manager Adriana Pecar
Technical Editor Teodora Smiljanic
Cover Designer InTech Design Team

First published March, 2012
Printed in Croatia

A free online edition of this book is available at www.intechopen.com
Additional hard copies can be obtained from

Angioplasty, Various Techniques and Challenges in Treatment of Congenital and
Acquired Vascular Stenoses, Edited by Thomas Forbes
p. cm.

ISBN 978-953-51-0084-3

ȱ

ȱ




Contents
ȱ
Preface IX
Chapter 1 Percutaneous Angioplasty and
Stenting for Mesenteric Ischaemia 1
Emily He

and Stephen M. Riordan
Chapter 2 Cerebral Hyperperfusion
Syndrome After Angioplasty 9
D. Canovas, J. Estela, J. Perendreu, J. Branera,
A. Rovira, M. Martinez and A. Gimenez-Gaibar
Chapter 3 Below the Knee Techniques: Now and Then 41
Daniel Brandão, Joana Ferreira, Armando Mansilha
and António Guedes Vaz
Chapter 4 Investigation of the Oxidative Stress, the
Altered Function of Platelets and Neutrophils,
in the Patients with Peripheral Arterial Disease 63
Maria Kurthy, Gabor Jancso, Endre Arato, Laszlo Sinay,
Janos Lantos, Zsanett Miklos, Borbala Balatonyi, Szaniszlo Javor,
Sandor Ferencz, Eszter Rantzinger, Dora Kovacs, Viktoria Kovacs,

Zsofia Verzar, Gyorgy Weber, Balazs Borsiczky and Erzsebet Roth
Chapter 5 Antithrombotic Therapy After Peripheral Angioplasty 89
Beniamino Zalunardo, Diego Tonello, Fabio Busato,
Laura Zotta, Sandro Irsara and Adriana Visonà
Chapter 6 Evidence-Based Invasive Treatments for Cerebral Vasospasm
Following Aneurysmal Subarachnoid Hemorrhage 105
Geoffrey Appelboom, Adam Jacoby, Matthew Piazza
and E. Sander Connolly
Chapter 7 Angiography for Peripheral Vascular Intervention 121
Yoshiaki Yokoi
Chapter 8 Arterial Angioplasty in Congential Heart Disease 169
Thomas J. Forbes, Srinath Gowda and Daniel R. Turner
VI Contents

Chapter 9 Carotid Angioplasty 189
Parth Shah and Michael Dahn
Chapter 10 Revascularization of Tibial and Foot Arteries:
Below the Knee Angioplasty for Limb Salvage 209
Marco Manzi, Luis Mariano Palena and Giacomo Cester



ȱȱ


ȱ



Preface

ȱ
!To the patients whom we treat, allowing us to slowly convert the !art of medicine9 into the
!science of medicine9.
!"#$% &'$()*('$&"'+,% /#&0&+'#% 1(,&(*(% $.+$% 2'3)(+% 4)5('$6&78% 9."% -():");(3% $.(%
:&)#$%#500(##:5,%0")"'+)/%+'7&"-,+#$/%&'%<=>>%&'%?5)&0.8%@9&$6(),+'38%1(7+'%$.(%()+%":%
,(##%&'*+#&*(%&'$()*('$&"'%-():");(3%*&+%$.(%$)+'#0+$.($()%)"5$(A%%2$%$.+$%$&;(8% &'%.&#%
:&)#$%0+#(8%5$&,&6&'7%+%kitchen-built%0+$.($()8%.(%#500(##:5,,/%-():");(3%3&,+$&"'%":%+'%BCD%
,(#&"'%":%+%E%;;%#(0$&"'%":%$.(%,(:$%+'$()&")%3(#0('3&'7%+)$()/A%%F(%-)(#('$(3%.&#%:&)#$%
:"5)% 0")"'+)/% +'7&"-,+#$/% 0+#(#% +$% $.(% G<=>>% 2;()&0+'% F(+)$% 2##"0&+$&"'H% ;(($&'7%
+'3% $.(% )(#$8% $.(/% #+/8% 9+#% .&#$")/A% % I+#0&'+$&'7,/8% +$%$.(% <CJ/(+)% +''&*()#+)/% ":% $.(%
&'&$&+,%-+$&('$8%$.(%-+$&('$%5'3()9('$%(,(0$&*(%)(-(+$%+'7&"7)+ /%9.&0.%'"$(3%$.+$%$.(%
K2L%'+))"9&'7%)(;+&'(3%+,;"#$%-():(0$,/%(M-+'3(3A%%@+3,/8%$.(%4();+'%0+)3&","7&#$8%
+,"'7%9&$.%.&#%9&:(8%$)+7&0+,,/%3&(3%&'%+%-,+'(%0)+#.%"'%N0$"1()%O>8%<=BP%+$%$.(%/"5'7%
+7(%":%QRA%%S:%.(%9+#%+,&*(%$"3+/8%.(%9"5,3%1(%+;+6(3%+$%$.(%-)"7)(##%1(&'7%;+3(%&'%
$.(%+'7&"-,+#$/%+)('+%:")%$.(%$)(+$;('$%":%0"'7('&$+,%+'3%+0T5&)(3%*(##(,%#$('"#&#A%%L)A%
4)5('$6&7U#% &'&$&+,% :")+/% &'$"% $.(% 0")"'+)/% 9"),3% #()*(3% +#% $.(% G,+5'0.% -+3H% :")% $.(%
3(*(,"-;('$%":%&3(+#%+'3%$(0.'","7/%&'%$.(%$)(+$;('$%":%-()& ()+,%*+#05,+)%,(#&"'#A%
I")% T5&$(% #";(% $&;(% $.(% $)(+$;('$% ":% 0")"'+)/% +)$()/% -+$.","7/% .+#% ,(+3% $.(% 9+/%
$"9+)3#%$.(%3(*(,"-;('$%+'3%$)(+$;('$%":%"$.()%*+#05,+)%,(#&"'#AA%
V.(%-+#$%$.)((%3(0+3(#%.+#%#(('%+'%(M-,"#&"'%&'%&'$()*('$&"'+,%$(0.'&T5(#%$"%$)(+$%1"$.%
0"'7('&$+,%+'3%+0T5&)(3%,(#&"'#%&'%$.(%*+#05,+)%#/#$(;A%%W.('%S%9+#%:&)#$%+#X(3%$"%(3&$%
$.&#%1""X%"'%+'7&"-,+#$/8%&$%0+;(%$"%;/%#5)-)&#(%$.+$%+%#&;&,+)%1""X%3(+,&'7%9&$.%$.(%
$(0.'&T5(#% +'3% &##5(#% ":% $.(#(% 0"'7('&$+,% +'3% +0T5&)(3% ,(#&"'#% .+3% '"$% 1(('%
-)(*&"5#,/%5'3()$+X('A%%Y()$+&',/%&'3&*&35+,%0.+-$()#%+'3%)(-")$#%.+*(%1(('%9)&$$('%
&'% $.(#(% +)(+#8% $."57.% '"% :");+,% 1""X% 3&#05##&'7% $.(% $(0.'&0+,% +#% 9(,,% +#% 05))('$%
"'7"&'7%0.+,,('7(#%&'%$.(#(%+)(+#%.+*(%0";-&,(3%&'%"'(%#($$&'7A%
S'%-+)$&05,+)8%$.(%-+#$%3(0+3(%.+#%#(('%+%#&7'&:&0+'$%+3*+'0(;('$%&'%1+,,""'8%9&)(8%+'3%
0+$.($()%$(0.'","7/%&'%$.(%$)(+$;('$%":%0";-,&0+$(3%0"'7('&$+,%+'3%+0T5&)(3%*+#05,+)%
,(#&"'#A%V.&#%3(0+3(% .+#%1")'%9&$'(##% $"% $.(%3(*(,"-;('$% ":%+'7&"-,+#$/% -)"0(35)(#%
$.+$% ;+'/% &'$()*('$&"'+,&#$#% .+3% '(*()% &;+7&'(3% 1(&'7% +1,(% $"% $)(+$% *&+% $.(%

$)+'#0+$.($()% )"5$(8% (#-(0&+,,/% &'% $.(% -()& ()+,% +)('+A% % V.(% &;-)"*(;('$% ":% #$('$%
$(0.'","7/8%(#-(0&+,,/% )(7+)3&'7%$)+0X&'7% 0+-+1&,&$&(#% ":% $.(%'(9()% 7('()+$&"'% #$('$#8%
X Preface

.+*(% -,+/(3% +% #&7'&:&0+'$% )",(% &'% $.(% $)(+$;('$% ":% $")$5"5#% *+#05,+)% ,(#&"'#% $.+$%
"$.()9&#(%9()(%(M0,5#&*(,/%)(,(7+$(3%$"%1(%$)(+$(3%&'%$.(%#5)7&0+,%"-()+$&'7%$.(+$()A%%%
2$%:&)#$%,""X8%&'%)(*&(9&'7%$.(%$"-&0#%0"*()(3%&'%$.&#%1""X8%"'(U#%&'&$&+,%&;-)(##&"'%;+/%
1(%$.+$%$.&#%&#%+%0";-&,+$&"'%":%;5,$&-,(%3&::()('$%$/-(#%":%,(#&"'#%+'3%$.(%$)(+$;('$%":%
$.(#(% ,(#&"'#A%% V.(% 0";;"'% $.)(+3%,&'X&'7%$.(#(% -)"0(35)(#% $"7($.()% )(,+$(#% $"% 1"$.%
$.(%$(0.'","7/%#.+)(3%1($9(('%3&#0&-,&'(#8%+'3%$.(%0";;"'%$(0.'&T5(#%5#(3%$"%$)(+$%
*+)&"5#%,(#&"'#%$.)"57."5$%$.(%*+#05,+)% #/#$(;A%%2%-():(0$% (M+;-,(%":%$.&#% )(,+$(#%$"%
0.)"'&0%$"$+,% "1#$)50$&*(%,(#&"'#%&'% $.(% -()& ()+,%*+#05,+)% #/#$(;%+'3% $.(% $(0.'&T5(%
5#(3%$"%"*()0";(%$(0.'&0+,%0.+,,('7(#%":%+%0";-,($(,/%"00,53(3%0")"'+)/%*(##(,A%%
N'(% #."5,3% '"$% 0"'#&3()% $.&#% $(M$1""X% &#%+%0";-('3&5;%":%"1#05)(%&'$()*('$&"'+,%
-)"0(35)(#A%S%1(,&(*(%$.+$%$.&#%$(M$1""X%)(-)(#('$#%$.(%7)(+$(#$%7)"9$.%-"$('$&+,%+)(+%&'%
;50.%":%&'$()*('$&"'+,%0+)3&"*+#05,+)%;(3&0&'(A%%I")%(M+;-,(8%+#%$(0.'&T5(#%0"'$&'5(%
$"% &;-)"*(% )(7+)3&'7% )(J*+#05,+)&6+$&"'% &:% 3&#$+,% (M$)(;&$&(#8% (#-(0&+,,/% &'% -+$&('$#%
9&$.%-()& ()+,%*+#05,"-+$./%#(0"'3+)/%$"%3&+1($(#8%$('#%":%$."5#+'3#%":%-+$&('$#%9&,,%
1('(:&$%:)";%'"$%.+*&'7%$"%5'3()7"%+;-5$+$&"'%-)"0(35)(#8%")%+$%,(+#$%:")(#$+,,&'7%$.(%
+;-5$+$&"'%-)"0(35)(%5'$&,%+%;50.%,+$()%$&;(A%%V.(%$)(+$;('$#8%9.($.()%&$%1(%)(,+$(3%
$"%0+)"$&3%#$('"#&#8%;(#('$()&0%&#0.(;&+8%'(5)+,%*+#05,+)%#-+#;8%")%0"'7('&$+,%*+#05,+)%
,(#&"'#8%.+*(%$.(%-"$('$&+,%":%)(+0.&'7%;&,,&"'#%":%-+$&('$#%(*()/%/(+)A%
V.&#% 1""X% +,#"% 1)&37(#% &##5(#% )(,+$(3% $"%0";-,&0+$&"'#% ")% "$.()% 0.+,,('7(#% )(,+$(3% $"%
-():");&'7% +77)(##&*(% +'7&"-,+#$/% -)"0(35)(#A% % W.($.()% &$% 1(% ./-()-():5#&"'%
#/'3)";(%:",,"9&'7%+77)(##&*(%+'7&"-,+#$/%")% "M/7('% #$)(##% +'3%+,$()(3%:5'0$&"'%":%
-,+$(,($#% &'% -+$&('$#% 9&$.% -()& ()+,% +)$()&+,% *+#05,+)% 3&#(+#(8% '"$% "',/% 3"%
&'$()*('$&"'+,&#$#% '((3% $"% 1(% X'"9,(37(+1,(% &'% $.(% $(0.'&T5(% &'% -():");&'7% +'%
&'$()*('$&"'8% $.(/% +,#"% ;5#$% .+*(% +% #$)"'7% 5'3()#$+'3&'7% ":% 9.+$% $.(% -"$('$&+,%
)+;&:&0+$&"'#%+)(%1"$.%"'%+'%+'+$";&0%+'3%;",(05,+)%,(*(,A%
V"% ('38% $.&#% :&)#$% (3&$&"'% "'% 2'7&"-,+#$/% 9&,,% ."-(:5,,/% &'#-&)(% &'$()*('$&"'+,&#$#% $"%

G0)"##J,&'XH% $.(&)% (M-()&('0(% 9&$.% "$.()% &'$()*('$&"'+,&#$#% )(7+)3&'7% $.(% $(0.'&T5(#%
5#(3% $"% $)(+$% 0";-,&0+$(3% ,(#&"'#A% % S% -()#"'+,,/% :((,% $.+$% 0";;5'&0+$&"'% &#% $.(% ;"#$%
&;-")$+'$% +,,/% $"% "*()0";&'7% 0.+,,('7(#% &'% 1"$.% +0T5&)(3% +'3% 0"'7('&$+,% *+#05,+)%
,(#&"'#A% % F"-(:5,,/% $.&#% 1""X% 9&,,% &'#-&)(% $.&#% $"% "005)% 1($9(('% &'$()*('$&"'+,%
)+3&","7&#$#8%0+)3&","7&#$#8%'(5)","7&#$#8%+'3%'(5)"#5)7("'#A%%S%9"5,3%'"$%1(%#5)-)&#(38%
9&$.% $.(% 0"'$&'5(3% (M-,"#&"'% ":% +% $(0.'","7/% &'%$.&#%+)(+8%$.+$%)(*&#&"'%":%$.&#%1""X%
9&,,%1(%)(T5&)(3%9&$.&'%$.(%'(M$%>J<C%/(+)#A%%I&'+,,/8%"'(%9"5,3%1(%)(;&##%&'%'"$%7&*&'7%
0)(3&$% $"% W+)'()% I")#;+''% :")% .&#% &'#&7.$% &'%$.(%0+$.($()&6+$&"'%-)"0(35)(%+'38%+#%
-)(*&"5#,/%;('$&"'(38%2'3)(%4)5('$6&7%&'%,+5'0.&'7%5#%&'$"%+'%&'$()*('$&"'+,%()+%:")%
$.(%$)(+$;('$% ":% *+#05,+)% #$('"#&#A% % N'% $.(%#."5,3()#% ":% $.(#(%$9"% 7&+'$#% Z+'3% ;+'/%
"$.()#[%9(%+)(%+1,(%$"%-)"0((3%"'$"%+'%(M0&$&'7%+'3%0.+'7&'7%9"),3%":%&'$()*('$&"'+,%
0+)3&","7/A%
S%9"5,3%,&X(%$"%7)(+$,/%+0X'"9,(37(%$.(%+5$.")#%":%$.&#%1""X%:")%$.(&)%$&;(%&'%9)&$&'7%
$.(% 0.+-$()#A% % W&$."5$% $.(&)% 3(3&0+$&"'% $"% #.+)&'7% $.(&)% &'$()*('$&"'+,% (M-()$&#(8% $.&#%
P r e f a c e X I

1""X%9"5,3%'(*()%0";(%$"%:)5&$&"'A%%S%+,#"%9"5,3%,&X(%$"%$.+'X%;/%,"*(,/%9&:(%!+)&(%
9."8%9&$."5$%.()%3(3&0+$&"'%$"%)+&#&'7%'&'(%0.&,3)('%Z;/#(,:%&'0,53(3[8%S%9"5,3%'(*()%
.+*(% .+3% $.(% )(;"$(% -"##&1&,&$/% :")% 1(&'7% +1,(% $"% :&'3% $.(% $&;(% $"% 5'3()$+X(% $.&#%
('3(+*")A%%%%
%
Dr. Thomas Forbes
W+/'(%@$+$(%\'&*()#&$/%]%Y.&,3)('U#%F"#-&$+,%":%!&0.&7+'8%L($)"&$%%
\@2%
%

1
Percutaneous Angioplasty and
Stenting for Mesenteric Ischaemia
!"#$%&'(

)&
*+,& (/0(+&12&3#45,*+
6&
1
Gastroenterology Registrar, Gastrointestinal and Liver Unit
Prince of Wales Hospital, Sydney
2
Senior Staff Specialist, Gastrointestinal and Liver Unit, Prince of Wales Hospital
Sydney, Australia and Professor of Medicine (Conjoint)
University of New South Wales, Sydney
Australia
1. Introduction
1(7(+.(5#8&#780*("#*& ,9(& .4&#"/*#5(,& *5.(5#*$& 79//$%& #7& *+& #"/45.*+.& 8*97(& 4:& *;,4"#+*$&
/*#+<& (7/(8#*$$%& #+& 4$,(5& /*.#(+.7& =#.0& 5#7>&:*8.457&:45&?*789$*5&,#7(*7(2&@+.#$&5(8(+.$%<&
795A#8*$& 5(?*789$*5#7*.#4+& /548(,95(7& 7980& *7& (+,*5.(5(8.4"%& *+,& *45.4B84($#*8& 45& *45.4B
"(7(+.(5#8& ;%/*77& A5*:.#+A& =(5(& .0(& 4+$%& *?*#$*;$(& .5(*."(+.& 4/.#4+7& :45& /*.#(+.7& =#.0&
"(7(+.(5#8& #780*("#*2& '4=(?(5<&5(/45.(,&5*.(7&4:&/(5#B4/(5*.#?(&"*C45&84"/$#8*.#4+7&*+,&
"45.*$#.%& *5(& 0#A0<& #+:$9(+8(,& ;%& *& 0#A0& /5(?*$(+8(& 4:& 7#A+#:#8*+.& /*.#(+.& 84B"45;#,#.#(72&
D(589.*+(497&*+A#4/$*7.%&*+,&7.(+.#+A&0*?(&;((+&704=+&.4&;(&(::(8.#?(&*+,&7*:(&*$.(5+*.#?(7&
.4& 795A#8*$& 5(?*789$*5#7*.#4+& #+& 0#A0B5#7>& /*.#(+.7& =#.0& "(7(+.(5#8& #780*("#*2& E+,((,<& #+&
0#A0B795A#8*$& 5#7>& /*.#(+.7& *+,& #+& .047(& =#.0& 79#.*;$(& $(7#4+7<& 7980& (+,4?*789$*5&
5(?*789$*5#7*.#4+&0*7&("(5A(,&*7&.0(&/5#"*5%&.5(*."(+.&"4,*$#.%2&&
'(5(<& =(& 5(?#(=& 8955(+.& 84+8(/.7& #+& .0(& ,#*A+47#7<& .5(*."(+.& 7($(8.#4+& *+,& 49.84"(7& :45&
/(589.*+(497&*+A#4/$*7.%&*+,&7.(+.#+A&:45&/*.#(+.7&=#.0&(#.0(5&8054+#8&45&*89.(&"(7(+.(5#8&
#780("#*2
2. Chronic mesenteric ischaemia
F054+#8&"(7(+.(5#8&#780*("#*&GF1EH&"47.&84""4+$%&*5#7(7&:54"&*.0(5478$(54.#8&,#7(*7(7&4:&
.0(& "(7(+.(5#8& *5.(5#(72& I.0(5& 8*97(7& 4:& F1E& #+8$9,(& *45.#8& ,#77(8.#4+<& :#;54"9789$*5&
,%7/$*7#*<&?*789$#.#,(7&*+,&"(,#*+&*589*.(&$#A*"(+.&7%+,54"(2&
J.0(5478$(54.#8& ,#7(*7(& 4:& .0(& "(7(+.(5#8& *5.(5#(7& #7& (7.#"*.(,& .4& 48895& #+& )KL& 4:& /*.#(+.7&

4?(5& .0(& *A(& MN& %(*57& G'*+7(+& (.& *$2<& 6OOPH2& Q(7/#.(& #.7& /5(?*$(+8(<& .0(& "*C45#.%& 4:& .0(7(&
/*.#(+.7& *5(& *7%"/.4"*.#8& *7& *& 5(79$.& 4:& .0(& (R.(+7#?(& 84$$*.(5*$& 8#589$*.#4+& ;(.=((+& .0(&
8($#*8& .59+><& 79/(5#45& "(7(+.(5#8& *5.(5%& G-1JH& *+,& #+:(5#45& "(7(+.(5#8& *5.(5%& GE1JH2&
S0(.0(5&45& +4.& #780*("#*& (+79(7& ,(/(+,7& 4+& .0(&7#.(& 4:& .0(&7.(+47#7& 45& 488$97#4+& *+,&.0(&
,(?($4/"(+.&45&4.0(5=#7(&4:&84$$*.(5*$&?(77($7&GT4::54%&(.&*$2<&6OOUH2&F1E&.%/#8*$$%&488957&#+&
/*.#(+.7&=04&0*?(&-1J&$(7#4+7&#+&84+C9+8.#4+&=#.0&$(7#4+7&#+&(#.0(5&.0(&8($#*8&.59+>&45&E1J2&
'4=(?(5<& "(7(+.(5#8& #780*("#*& 8*+& *$74& ,(?($4/& #+& /*.#(+.7& =#.0& *& 7#+A$(& ?(77($& $(7#4+2&
Q#7.*$& $(7#4+7& *5(& "45(& $#>($%& .4& ;(& 7%"/.4"*.#8& 84"/*5(,& =#.0& "45(& /54R#"*$& *5.(5#*$&
/*.04$4A%&,9(&.4&.0(&*;7(+8(&4:&*+&(::(8.#?(&84$$*.(5*$&8#589$*.#4+2&&
Angioplasty, Various Techniques and Challenges in
Treatment of Congenital and Acquired Vascular Stenoses

2
3. Clinical presentation
F1E&84""4+$%&*::(8.7&/(4/$(&4?(5&.0(&*A(&4:&MO&%(*57<&=#.0&=4"(+&.05((&.#"(7&"45(&$#>($%&
.4& ;(& *::(8.(,& .0*+& "(+& G'*+7(+& (.& *$2<& 6OOPH2& 147.& /*.#(+.7& 0*?(& "9$.#/$(& 8*5,#4?*789$*5&
5#7>&:*8.457&*+,&*.0(5478$(54.#8&84"/$#8*.#4+7&#+&4.0(5&?*789$*5&.(55#.45#(72&&
F$*77#8& 7%"/.4"7& 4:& F1E& #+8$9,(& /47./5*+,#*$& *;,4"#+*$& /*#+<& :(*5& 4:& (*.#+A& *+,&
7#A+#:#8*+.& =(#A0.& $4772& D*.#(+.7& "*%& *$74& /5(7(+.& =#.0& /(57#7.(+.& +*97(*& *+,& ,#*5504(*2&
V0(7(&7%"/.4"7&*5(&+4+B7/(8#:#8&*+,&(R.(+7#?(&#+?(7.#A*.#4+7&*5(&A(+(5*$$%&9+,(5.*>(+&.4&
(R8$9,(&4.0(5&/*.04$4A#(7&7980&*7&A*7.54#+.(7.#+*$&45&/*+85(*.#8&"*$#A+*+8%2&&
4. Diagnosis
Q9/$(R&9$.5*749+,&#7&*&97(:9$<&+4+B#+?*7#?(&785((+#+A&.(7.&:45&"(7(+.(5#8&#780*("#*&G14+(.*&
(.&*$2<&)UUWH&GV*;$(&)H2&E.7&*8895*8%&#7&*::(8.(,&;%&4/(5*.45&(R/(5#(+8(&*+,&/*.#(+.&:*8.457&7980&
*7& :*7.#+A& 7.*.97<& ;4,%& 0*;#.97& *+,& /5(7(+8(& 4:& ;4=($& A*72& FVB*+A#4A5*/0%& *+,& 13B
*+A#4A5*/0%&*5(&4:&?*$9(&#+&8*7(7&=0(5(&,9/$(R&9$.5*749+,&#7&#+84+8$97#?(&GF*,("*5.#5#&(.&
*$2<&6OOXY&'45.4+&(.&*$2<&6OOKY&T*#77%&(.&*$2<&6OO6H2&FVB*+A#4A5*/0%&*$74&/54?#,(7&(R8($$(+.&WBQ&
*+*.4"#8*$& 5(84+7.598.#4+& .4& :*8#$#.*.(& /$*++#+A& :45& (+,4?*789$*5& 5(?*789$*5#7*.#4+2&
Z(?(5.0($(77<&,#A#.*$&79;.5*8.#4+&*+A#4A5*/0%&5("*#+7&.0(&A4$,& 7.*+,*5,&#+&(?*$9*.#+A&.0(&
,(A5((&4:&7.(+47#7&#+&"(7(+.(5#8&?(77($72&&

&
[(77($& Q9/$(R&85#.(5#*& -(+7#.#?#.%& -/(8#:#8#.%& J8895*8%&
-1J& D-[&\&6KN8"]7 U6L& UML& UML&
F4($#*8&.59+> D-[&\&6OO8"]7 XKL& X6L& X6L&
D-[^&/(*>&7%7.4$#8&?($48#.%&
V*;$(&)2&Q9/$(R&9$.5*749+,&85#.(5#*&:45&,(.(8.#+A&\KOL&7.(+47#7&#+&"(7(+.(5#8&?(77($7&G:54"&
14+(.*&(.&*$2<&)UUWH2&&
5. Treatment options
V5(*."(+.&4:&7%"/.4"*.#8&F1E&#7&*#"(,&*.&5($#(?#+A&7%"/.4"7&*+,&/5(?(+.#+A&/54A5(77#4+&.4&
*89.(& "(7(+.(5#8& #780*("#*& GJ1EH& *+,& #+.(7.#+*$& #+:*58.#4+2& D54/0%$*8.#8& .5(*."(+.& 4:&
*7%"/.4"*.#8&/*.#(+.7&#7&84+.54?(57#*$2&V0(&5#7>&4:&/54A5(77#+A&.4&J1E&#7&A5(*.(7.&#+&/*.#(+.7&
=#.0&.05((B?(77($&,#7(*7(&=#.0&*+&(7.#"*.(,&4+(&.0#5,&4:&.0(7(&/*.#(+.7&/54A5(77#+A&.4&#+.(7.#+*$&
#+:*58.#4+&#:& $(:.&9+.5(*.(,&G_4$>"*+& (.& *$2<&6OOPH2&V0(&/54A+47#7& #7&5($*.#?($%&;(+#A+& #+& .047(&
=#.0&7#+A$(B?(77($&,#7(*7(2&E+&/*5.#8#/*+.7&4:&.0(&F*5,#4?*789$*5&'(*$.0& 9,%&=04&=(5(&:49+,&
.4&0*?(&#74$*.(,&84($#*8&.59+>&45&"(7(+.(5#8&*5.(5%&,#7(*7(&4+&,9/$(R&9$.5*749+,<&.0(5(&=*7&+4&
#+85(*7(,&5#7>&4:&"45.*$#.%<&#+.(7.#+*$&#+:*58.#4+&45&,(?($4/"(+.&4:&7%"/.4"7&84+7#7.(+.&=#.0&
F1E&4?(5&*&"(,#*+&:4$$4=&9/&/(5#4,&4:&M2N%(*57&GS#$74+&(.&*$2<&6OOMH2&&
V0(&A4$,&7.*+,*5,&4:&.5(*."(+.&0*7&.5*,#.#4+*$$%&;((+&795A#8*$&5(?*789$*5#7*.#4+&#+&.0(&:45"&
4:& ;%/*77<& (+,*5.(5(8.4"%& 45& (";4$(8.4"%2& `#?(+& .0*.& /*.#(+.7& *::(8.(,& ;%& F1E& *5(&
A(+(5*$$%&"*$+495#70(,<&4:&*,?*+8(,&*A(&*+,&0*?(&"9$.#/$(&8*5,#4?*789$*5&84B"45;#,#.#(7<&
.0(5(& #7& 84+7#,(5*;$(& /(5#B4/(5*.#?(& "45.*$#.%& GOB)KLH& *+,& "45;#,#.%& G)NBWWLH& *7748#*.(,&
=#.0&795A#8*$&5(?*789$*5#7*.#4+&G_49A#*7&(.&*$2<&6OOUH2&&
!+,4?*789$*5&5(?*789$*5#7*.#4+&#7&#+85(*7#+A$%&;(#+A&4::(5(,&.4&/*.#(+.7&*::(8.(,&;%&F1E2&E+&
*&$*5A(&@-&5(A#7.5%&7.9,%&84"/5#7#+A&4:&NNXW&/*.#(+.7&.5(*.(,&:45&F1E&,95#+A&.0(&%(*57&)UXX&

Percutaneous Angioplasty and Stenting for Mesenteric Ischaemia

3
.4& 6OOM& G-80(5"(5045+& (.& *$2<& 6OOUH<& .0(& +9";(5&4:&(+,4?*789$*5&/548(,95(7&7.(*,#$%&
#+85(*7(,<& 795/*77#+A& *$$& 795A(5%& :45& F1E& #+& 6OO62& !+,4?*789$*5& 5(?*789$*5#7*.#4+& #7&

*7748#*.(,&=#.0&*&$4=(5&#+B047/#.*$&"45.*$#.%&*+,&"45;#,#.%&5*.(&*7&=($$&*7&7045.(5&$(+A.0&4:&
7.*%2& -#A+#:#8*+.$%& $4=(5& 5*.(7& 4:& ;4=($& 5(7(8.#4+<& *7& =($$& *7& :(=(5& 5(+*$<& 8*5,#*8& *+,&
5(7/#5*.45%& 84"/$#8*.#4+7& 0*?(& ;((+& 5(/45.(,&#+&/*.#(+.7&=04&5(8(#?(,&(+,4?*789$*5&
5(?*789$*5#7*.#4+&84"/*5(,&.4&795A#8*$$%B.5(*.(,&849+.(5/*5.7&GV*;$(&6H2&J&$*.(5&*+*$%7#7&4:&
/9;$#70(,& ,*.*& 84+8(5+#+A& /548(,95(7&/(5:45"(,&;(.=((+&6OOO&*+,&6OOU&7#"#$*5$%&
,("4+7.5*.(,&*&7#A+#:#8*+.$%&5(,98(,&/(5#B4/(5*.#?(&84"/$#8*.#4+&5*.(&#+&/*.#(+.7&"*+*A(,&
;%&(+,4?*789$*5&.0(5*/%&84"/*5(,&.4&795A(5%&G`9/.*&(.&*$2<&6O)OH2&
&
Endovascular
revascularisation
Surgical
revascularisation
p-
value
145.*$#.%& W2KL& )N2PL& aO2OO)&
I?(5*$$&"45;#,#.%& 6OL& WXL& aO2ON&
b4=($&5(7(8.#4+& WL& XL& aO2OO)&
F*5,#*8&(?(+.7& O2KL& N2UL& aO2OO)&
3(7/#5*.45%&(?(+.7& O2WL& N2KL& aO2OO)&
J89.(&5(+*$&:*#$95(& M2OL& )O2NL& aO2ON&
TI-&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
"(,#*+&G5*+A(H<&,*%7&
N&GOBUPH& ))&G)B)WNH& aO2OO)&
V*;$(&62&145.*$#.%<&"45;#,#.%<&/(5#B4/(5*.#?(&84"/$#8*.#4+7&*+,&$(+A.0&4:&7.*%&GTI-H^&
(+,4?*789$*5&5(?*789$*5#7*.#4+&?72&795A#8*$&5(?*789$*5#7*.#4+2&G*,*/.(,&:54"&-80(5"(5045+&
(.&*$2<&6OOUH&&
J& 7(5#497& /4.(+.#*$& 84"/$#8*.#4+& 4:& (+,4?*789$*5& .5(*."(+.& #7& .0(& /5(8#/#.*.#4+& 4:& *89.(&
#+.(7.#+*$& #780("#*& ;%& /$*c9(& (";4$#d*.#4+& 45&,#77(8.#4+&4:&.0(&*5.(5%2& *+,*5,&8*.0(.(5&
;*7(,& 7*$?*A(& .(80+#c9(7& 7980& *7& 7.(+.& ,(/$4%"(+.<& (";4$(8.4"%& 45& .054";4$%7#7& *5(&
979*$$%&7988(77:9$&#+& .5(*.#+A&.0(7(&84"/$#8*.#4+72&!"(5A(+8%&$*/*54.4"%&=#.0&"(7(+.(5#8&

;%/*77& *+,& ;4=($& 5(7(8.#4+& #7& *$74& 97(,& *7& 7*$?*A(& .5(*."(+.2& S(& 5(8(+.$%& 5(/45.(,& .0(&
488955(+8(& 4:& 7/$(+#8& #+:*58.#4+& 84"/$#8*.#+A& 4.0(5=#7(& 7988(77:9$& 8($#*8& *5.(5%& 7.(+.#+A<&
/5(79"*;$%&*7&*&84+7(c9(+8(&4:& ,#7.*$&(";4$#d*.#4+&4:&,#759/.(,&8*$8#:#8&/$*c9(<&=#.0& .0#7&
84"/$#8*.#4+& 5(/5(7(+.#+A& *& +4?($& 8*97(& 4:& *;,4"#+*$& /*#+& /47.B/548(,95(& GJ$"(#,*& e&
3#45,*+<&6OOXH2&
V0(&"47.&84""4+&/548(,95*$&84"/$#8*.#4+&4:&(+,4?*789$*5&.0(5*/%&5($*.(7&.4&.0(&/9+8.95(&
7#.(<&"*+#:(7.#+A&*7&(#.0(5&0*("4550*A(&45&.054";47#72&'*("4550*A(&#7&A(+(5*$$%&84+.54$$(,&
=#.0&$48*$&/5(7795(&*+,]45&#+C(8.#4+&4:&.054";#+2&E+7(5.#4+&4:&#+.(5?(+.#4+*$&70(*.07&#+&7"*$$&
*5.(5#(7&#7&*7748#*.(,&=#.0&*+&#+85(*7(,&5#7>&4:&.054";47#72&3*/#,&0(/*5#+#d*.#4+&*:.(5&70(*.0&
#+7(5.#4+&#7&979*$$%&*+&*,(c9*.(&/5(?(+.*.#?(&"(*795(2&
J+4.0(5& #"/45.*+.& #779(& #7& .0(& $4+A(5B.(5"& *5.(5#*$& /*.(+8%& 5*.(& #+& /*.#(+.7& .5(*.(,& ;%&
(+,4?*789$*5& "(*+7& 84"/*5(,& .4& .047(& "*+*A(,& 795A#8*$$%2& E+& *& 5(8(+.& 5(?#(=& 4:& W6X&
/*.#(+.7& 9+,(5A4#+A& (+,4?*789$*5& .5(*."(+.& :45& 8054+#8& "(7(+.(5#8& #780*("#*<& .0(& 4?(5*$$&
.(80+#8*$&7988(77&5*.(&=*7& U)L&*+,& #""(,#*.(&7%"/.4"*.#8&5($#(:&=*7&*80#(?(,&#+& X6L&4:&
/*.#(+.7& G_49A#*7& (.& *$2<& 6OOKH2& Q(7/#.(& .0(& #+#.#*$& 7988(77& 5*.(<& *//54R#"*.($%& 4+(& .0#5,& 4:&
/*.#(+.7&GXP]6U6H&*?*#$*;$(&:45&:4$$4=&9/&,(?($4/(,&5(7.(+47#7&4?(5&*&"(*+&:4$$4=&9/&/(5#4,&
4:&6M&"4+.072&V0(&WOB,*%&"45.*$#.%&5*.(&=*7&WBNL2&F$#+#8*$&7(5#(7&84"/*5#+A&(+,4?*789$*5&
*+,&795A#8*$&5(?*789$*5#7*.#4+&0*?(&704=+&.0*.&$4+A&.(5"&/*.(+8%&5*.(7&*+,&:5((,4"&:54"&
Angioplasty, Various Techniques and Challenges in
Treatment of Congenital and Acquired Vascular Stenoses

4
7%"/.4"7& "*%& ;(& #+:(5#45& #+& /*.#(+.7& =04& 0*?(& 0*,& (+,4?*789$*5& 5(?*789$*5#7*.#4+&
G_49A#*7&(.& *$2<& 6OOUY& J.>#+7& (.& *$2<& 6OOKY&_*7#5*AC*+& (.& *$2<& 6OO)H2& E+,((,<&*+& *+*$%7#7& 4:&*$$&
/9;$#70(,& $#.(5*.95(& 84"/*5#+A& 795A#8*$& *+,& (+,4?*789$*5& .5(*."(+.& 4/.#4+7& :45& F1E&
/(5:45"(,& ;(.=((+& 6OOO& *+,& 6OOU& 84+8$9,(,& .0*.& NB%(*5& /5#"*5%& /*.(+8%& 5*.(7& =(5(& W2X&
.#"(7&A5(*.(5&#+&.0(&795A#8*$&A549/&GDaO2OO)H<&=0#$(&:5((,4"&:54"&7%"/.4"7&*.&N&%(*57&=*7&
P2P& .#"(7& A5(*.(5& #+& /*.#(+.7& "*+*A(,& 795A#8*$$%& 84"/*5(,& .4& .047(& .5(*.(,& =#.0&
(+,4?*789$*5&.(80+#c9(7&G/aO2OO)H&G`9/.*&(.&*$2<&6O)OH2&
6. Angioplasty vs stenting

V0(5(&#7&A(+(5*$&*A5(("(+.&.0*.&7.(+.#+A&#7&#+,#8*.(,&:45&5(7#,9*$&7.(+47#7&:4$$4=#+A&/5#"*5%&
*+A#4/$*7.%&G,(:#+(,&*7&5(7#,9*$&7.(+47#7&4:&WOL&45&"45(<&45&/5(7795(&A5*,#(+.&0#A0(5&.0*+&
)N""'AH<&:45&47.#*$&45&(88(+.5#8&$(7#4+7<&45&*7&*&7*$?*A(&/548(,95(&:45&*89.(&,#77(8.#4+&*:.(5&
*+A#4/$*7.%&G_49A#*7&(.&*$2<&6OOKH2&&b*$$44+B(R/*+,*;$(&7.(+.7&*5(&/5(:(55(,&;(8*97(&4:&.0(#5&
*8895*8%&*+,&*;#$#.%&.4&A(+(5*.(&84+7#,(5*;$(&5*,#*$&:458(2&145(&,#7.*$&45&$4+A&$(7#4+7&"*%&;(&
;( (5&79#.(,&.4&7($:B(R/*+,*;$(&7.(+.7&A#?(+&.0(#5&:$(R#;#$#.%&GT4::54%&(.&*$2<&6OOUH2&&
_49A#*7& (.& *$& G6OOKH& 5(/45.(,& .0*.& .(80+#8*$& 7988(77& =*7& 7#A+#:#8*+.$%& 0#A0(5& =#.0& 7.(+.#+A&
84"/*5(,&=#.0&*+A#4/$*7.%&*$4+(&GUNL&?7&XWL<&/fO2OOKH<&*$.049A0&.0(&5*.(&4:&5(7.(+47#7&=*7&
*$74&0#A0(5&#+&.0(&7.(+.(,&79;A549/<&*&:#+,#+A&.0*.&"*%&0*?(&;((+&;#*7(,&;%&.0(&#+8$97#4+&4:&
(*5$#(5& 7.9,#(7& =0(5(& "45(& /5#"#.#?(& 7.(+.7& =(5(& 97(,& *+,& /(5#B/548(,95*$& *+.#84*A9$*+.&
*+,& *+.#/$*.($(.& .5(*."(+.& 5(A#"(+7& =(5(& +4.& 7.*+,*5,#d(,2& J& 5(8(+.& 8*7(& 7(5#(7&
,("4+7.5*.(,& .0*.& $4+AB.(5"& /*.(+8%& 5*.(& =*7& 0#A0(5& #+& /*.#(+.7& "*+*A(,& =#.0& /5#"*5%&
7.(+.#+A&84"/*5(,&.4&*+A#4/$*7.%&*$4+(&GQ*$#5#&(.&*$2<&6O)OH2&
7. Which vessel to treat
T#.(5*.95(& :54"& .0(& 795A#8*$& 5(?*789$*5#7*.#4+& 7( #+A& 0*7& 704=+& .0*.& 84"/$(.(&
5(?*789$*5#7*.#4+& 4:& .0(& 84($#*8& .59+>& *+,& -1J& #7& *7748#*.(,& =#.0& #"/54?(,& $4+AB.(5"&
49.84"(7& G1*.(4& (.& *$2<& )UUUY& 18J:((& (.& *$2<& )UU6Y& g4$(%& (.& *$2<& 6OOOH2& V0(& 7#"9$.*+(497&
.5(*."(+.&4:& .=4& ?(77($7& /5(?(+.7& 7%"/.4"& 5(8955(+8(&#+& .0(& (?(+.& 4:& 5(7.(+47#7& #+& (#.0(5&
*5.(5%2& E"/54?(,& A5*:.& /*.(+8%& *+,& 795?#?*$& =#.0& 84"/$(.(& 5(84+7.598.#4+& G18J:((& (.& *$2<&
)UU6H<& *+,& *& 0#A0(5& #+8#,(+8(& 4:& 7%"/.4"7& *+,& A5*:.& :*#$95(& =#.0& 7#+A$(& ?(77($& .0(5*/%&
Gg4$(%&(.&*$2<&6OOOH&0*?(&(*80&;((+&,("4+7.5*.(,2&&
V0(5(& #7& *& .(+,(+8%& .4& .5(*.& :(=(5& ?(77($7& =0(+& 80447#+A& (+,4?*789$*5& 5(?*789$*5#7*.#4+&
84"/*5(,&=#.0&795A#8*$&5(?*789$*5#7*.#4+&G_49A#*7&(.&*$2<&6OOUH2&V0(&84+?(+.#4+*$&*//54*80&
.4& (+,4?*789$*5& #+.(5?(+.#4+& #7& .4& .5(*.& -1J& $(7#4+7& #+& /5(:(5(+8(& .4& 8($#*8& .59+>& 45& E1J&
$(7#4+72& V0(5(& #7& 84+:$#8.#+A& (?#,(+8(& *7& .4& =0(.0(5& .5(*."(+.& 4:& ;4.0& -1J& *+,& 8($#*8&
*5.(5#(7&=#$$&/54,98(&;( (5&$4+AB.(5"&/*.(+8%2&J&5(8(+.& 7(5#(7&;%&D(8>&(.&*$&#+,#8*.(,&.0*.&
.=4B?(77($& .5(*."(+.& 5(79$.(,& #+& $4=(5& 7%"/.4"*.#8& 5(8955(+8(7<& #"/54?(,& /*.(+8%& *+,&
:(=(5&5(B#+.(5?(+.#4+7&GD(8>&(.&*$2<&6O)OH2&I+&.0(&4.0(5&0*+,<&-*5*8&(.&*$2&G6OOXH&,#,&+4.&5(/45.&
*+%& ,#::(5(+8(& #+& )& %(*5& /*.(+8%& ;(.=((+& 7#+A$(B?(77($& *+,& .=4B?(77($& .5(*."(+.<& =0#$(&
1*$A45&(.&*$2&G6O)OH&7#"#$*5$%&:49+,&#+&*&7.9,%&4:&$4+A(5&:4$$4=B9/&4:&W&%(*57&.0*.&.=4B?(77($&

8($#*8&&*5.(5%&*+,&-1J&7.(+.#+A&,#,&+4.&5(79$.&#+&#"/54?(,&49.84"(7&=0(+&84"/*5(,&=#.0&
7#+A$(B?(77($&-1J&7.(+.&/$*8("(+.&:45&F1E2&
V5*,#.#4+*$$%<&.0(5(&0*7&;((+&*&/5(:(5(+8(&:45&.5(*.#+A&7.(+4.#8&5*.0(5&.0*+&488$97#?(&$(7#4+7&
;%& (+,4?*789$*5& "(*+72& J$.049A0&.0(&/5(7(+8(&4:&*+&488$9,(,&?(77($&#7&+4.&*+&*;74$9.(&
84+.5*#+,#8*.#4+& .4& (+,4?*789$*5& #+.(5?(+.#4+<& .0(& /5*8.#8(& #+& "*+%& 8(+.5(7& #7& .4& 84+?(5.&

Percutaneous Angioplasty and Stenting for Mesenteric Ischaemia

5
:54"& (+,4?*789$*5& .4& 4/(+& 795A#8*$& 5(?*789$*5#7*.#4+& =0(+& *+& 488$97#4+& #7& :49+,&
G_*7#5*AC*+& (.& *$2<& 6OO)H2& & !+,4?*789$*5& /*77*A(& 4:& A9#,(& =#5(7& *+,& 7.(+.7& .0549A0& .4.*$$%&
488$9,(,&$(7#4+7&#7&*&.(80+#8*$$%&80*$$(+A#+A&/548(,95(&*+,&+4.&=#.049.&7#A+#:#8*+.&5#7>7&4:&
?(77($&/(5:45*.#4+&45&,#77(8.#4+2&J$.049A0&+4.&7.*.#7.#8*$$%&?*$#,*.(,<&.0(&,(A5((&4:&,#::#89$.%&
#7&$#>($%&.4&#+85(*7(&=#.0&.0(&$(+A.0&4:&488$97#4+2&J&.0(45(.#8*$&84+8(5+&*$74&(R#7.7&:45&/$*c9(&
:5*A"(+.*.#4+&*+,&,#7.*$&(";4$#d*.#4+<&=0#80&*$74&#+85(*7(7&=#.0&.0(&$(+A.0&4:&488$97#4+2&&&
J$.049A0&.0(&(::#8*8%&4:&(+,4?*789$*5&#+.(5?(+.#4+&#+&.5(*.#+A&488$9,(,&"(7(+.(5#8&?(77($7&
#7&+4.&=($$&(7.*;$#70(,<&(?4$?#+A&(+,4?*789$*5&.(80+4$4A%&=#.0&$4=B/54:#$(&7%7.("7&0*7&+4=&
"*,(& 5(8*+*$#d*.#4+& 4:& 488$9,(,& ?(77($7& :(*7#;$(2& T*+,#7& (.& *$2& G6OONH& 5(/45.(,& .(80+#8*$&
7988(77& *+,& )B%(*5& /*.(+8%& 5*.(7& 4:& )OOL& #+& U& /*.#(+.7& =#.0& "(7(+.(5#8& 488$97#4+2& J& 8*7(&
7(5#(7& ;%& D(8>& (.& *$& *$74& #+,#8*.(,& .0*.& /*.#(+.7& =#.0& 488$9,(,& -1J& =04& 9+,(5=(+.&
5(?*789$*5#7*.#4+&0*,&$4=(5&WB%(*5&7%"/.4"&5(8955(+8(&5*.(7<&=#.0&.05((&%(*5&/*.(+8%&5*.(7&
4:& UOL& :45& .5(*.(,& -1J& 488$97#4+7& ?(5797& POL&:45&9+.5(*.(,&-1J&488$97#4+7&GD(8>&(.&*$2<&
6O)OH2& V0#7& ,#::(5(+8(& 04=(?(5& =*7& +4.& 7.*.#7.#8*$$%& 7#A+#:#8*+.<& /477#;$%& ,9(& .4& .0(& 7"*$$&
+9";(57&4:&/*.#(+.7&7.9,#(,2&&
8. Surveillance of vessel patency
V0(5(&#7&*&$*8>&4:&9+#:45"#.%&#+&.0(&:4$$4=&9/&4:&/*.#(+.7&=04&0*?(&5(8(#?(,&(+,4?*789$*5&
.0(5*/%&:45&F1E2&J$.049A0&5(8955(+8(&4:&7%"/.4"7&#7&8455($*.(,&=#.0&5(7.(+47#7<&.0#7&*$4+(&
#7&+4.&*&5($#*;$(&/5(,#8.45&4:&?(77($&/*.(+8%<&=#.0&7(+7#.#?#.%&*7&$4=&*7&WWL&:45&,(.(8.#4+&4:&
5(7.(+47#7&G181#$$*+&(.&*$2<&)UUNH2&g*#$95(&.4&,#*A+47(&/54A5(77#?(&,#7(*7(&#+&*7%"/.4"*.#8&
/*.#(+.7&"*%&5(79$.&#+&.0(&79;7(c9(+.&,(?($4/"(+.&4:&*89.(&"(7(+.(5#8&.054";47#72&V0#7&#7&*&

/4.(+.#*$$%& :*.*$& ?*789$*5& ("(5A(+8%& =#.0& 4?(5*$$& "45.*$#.%&5*.(& 5*+A#+A& :54"& W6L& .4& MNL&
GD*5>&(.&*$2<&6OO6H2&

J;,4"#+*$&,9/$(R&9$.5*74+4A5*/0%&#7&.0(&"47.&84""4+$%&97(,&"(.04,&4:&795?(#$$*+8(&,9(&
.4& #.7& +4+B#+?*7#?(& +*.95(2& J$.049A0& ,9/$(R&9$.5*74+4A5*/0%&0*7&;((+&?*$#,*.(,&#+&.0(&
,#*A+47#7&4:&"(7(+.(5#8&*5.(5#*$&7.(+47#7&Gh=4$*>&(.&*$2<&)UUXH<&.0(5(&#7&+4&8955(+.&84+7(+797&
4+&=0#80&?($48#.%&85#.(5#*&7049$,&;(&97(,&.4&,(:#+(&0#A0BA5*,(&5(8955(+.&,#7(*7(&G_*7#5*C*+&
(.& *$2<& 6OO)Y& J5"7.54+A& (.& *$2<& 6OOKY& g(+=#8>& (.& *$2<& 6OOKH2& FVB*+A#4A5*/0%& *+,& 13B
*+A#4A5*/0%& *5(& *$.(5+*.#?(& "4,*$#.#(7& 4:& #"*A#+A<& *$.049A0& ,#A#.*$& 79;7.5*8.#4+&
*+A#4A5*/0%& #7& A(+(5*$$%& 84+7#,(5(,& .0(& A4$,& 7.*+,*5,2& V0(5(& #7& *& /4.(+.#*$& 54$(& :45&
:9+8.#4+*$& 7.9,#(7& 7980& *7& A*7.54#+.(7.#+*$& .4+4"(.5%& .4& ,(.(8.& "(7(+.(5#8& #780("#*& *+,&
A9#,(&.5(*."(+.&GI (&(.&*$2<&6OOXH2&&&
9. Acute mesenteric ischemia
J89.(&"(7(+.(5#8&#780("#*&#7&*7748#*.(,&=#.0&*&,*9+.#+A&"45.*$#.%&5*.(&4:&A5(*.(5&.0*+&NOL&
G-80(5"(5045+& (.& *$2<& 6OOUH2& D54"/.& ,#*A+47#7& *+,& #+7.#.9.#4+& 4:& 5(?*789$*5#7*.#4+& .0(5*/%&
*5(&8598#*$&:45&*&7988(77:9$&49.84"(2&&
!+,4?*789$*5&.5(*."(+.&:45&J1E&=*7&.5*,#.#4+*$$%&5(7(5?(,&:45&7($(8.(,&/*.#(+.7&=04&0*?(&
/540#;#.#?(& 4/(5*.#?(& 5#7><& +4& 8$#+#8*$& 7#A+7& 4:& /(5#.4+(*$& #+:$*""*.#4+<& 45& .047(& =#.0& *&
84+.*"#+*.(,&/(5#.4+(*$&8*?#.%&*+,&+4&*9.4A(+497&?(77($&*?*#$*;$(&:45&A5*:.#+A&GT4::54%&(.&
*$2<&6OOUH2&S#.0&(?4$?#+A&(R/(5.#7(&*+,&.(80+4$4A#8*$&*,?*+8("(+.7&#+&(+,4?*789$*5&.0(5*/%<&
.0(5(&0*7&;((+&*+&#+85(*7(&#+&.0(&97(&4:&(+,4?*789$*5&5(?*789$*5#7*.#4+&:45&.5(*."(+.&4:&J1E2&
E+&.0(&@-&5(A#7.5%&7.9,%&4:&N6WK&/*.#(+.7&.5(*.(,&:45&J1E<&.0(&49.84"(7&4:&/*.#(+.7&=04&=(5(&
.5(*.(,& =#.0& (+,4?*789$*5& #+.(5?(+.#4+& =(5(& 84"/*5(,& .4& .047(& =04& =(5(& .5(*.(,& =#.0&
Angioplasty, Various Techniques and Challenges in
Treatment of Congenital and Acquired Vascular Stenoses

6
795A(5%&G-80(5"(5045+&(.&*$2<&6OOUH2&D*.#(+.7&=04&=(5(&.5(*.(,&=#.0&(+,4?*789$*5&"(*795(7&
.(+,(,& .4& 0*?(& 0#A0(5& 5*.(7& 4:& 8*5,#4?*789$*5& 84"45;#,#.#(7& .0*+& .047(& 9+,(5A4#+A& 4/(+&
795A#8*$&5(/*#5<&#+8$9,#+A&0%/(5.(+7#4+<&/(5#/0(5*$&?*789$*5&,#7(*7(<&8454+*5%&*5.(5%&,#7(*7(&

*+,&8054+#8&5(+*$&:*#$95(2&Q(7/#.(&.0(7(&9+:*?495*;$(&/*.#(+.&80*5*8.(5#7.#87<&"45.*$#.%&=*7&
7#A+#:#8*+.$%& $4=(5& #+& .0(& (+,4?*789$*5& A549/& 84"/*5(,& =#.0& .0(& 795A#8*$& A549/& G)ML& ?7&
WUL<&/aO2OO)H2&

E+&*&5(8(+.&5(.547/(8.#?(<&7#+A$(&8(+.5(&8*7(&7(5#(7&4:&KO&/*.#(+.7&=#.0&J1E<&.0(&$*5A(7.&7980&
8*7(&7(5#(7&.4&,*.(<&J5.0957&(.&*$2&G6O))H&,("4+7.5*.(,&.0*.&.0(&97(&4:&(+,4?*789$*5&.0(5*/%&
*7& /5#"*5%& .5(*."(+.& :45& J1E& /54,98(,& $4=(5& 84"/$#8*.#4+& 5*.(7& *+,& ;( (5& 49.84"(7&
GJ5.0957&(.&*$2<&6O))H2&Q95#+A&*&UB%(*5&7.9,%&/(5#4,<&(+,4?*789$*5&.0(5*/%&=*7&#+#.#*.(,&#+&NM&
/*.#(+.7& =0#$(& 795A#8*$& .0(5*/%& =*7& 97(,& #+& 6P& /*.#(+.72& I?(5*$$<& .(80+#8*$& 7988(77& :45&
(+,4?*789$*5& .0(5*/%& =*7& XKL2& g*#$95(7& #+& (+,4?*789$*5& .0(5*/%& =(5(& .5(*.(,& =#.0&
(";4$(8.4"%& #+& KXL& *+,& 5(?*789$*5#7*.#4+& #+& 66L2& -988(77:9$& (+,4?*789$*5& .5(*."(+.&
5(79$.(,&#+&*&"45.*$#.%&5*.(&4:&WML<&=0#80&=*7&7#A+#:#8*+.$%&$4=(5&84"/*5(,&=#.0&*&5*.(&4:&
NOL&#+&.047(&.5(*.(,&795A#8*$$%&G/aO2ONH2&D*.#(+.7&=04&:*#$(,&(+,4?*789$*5&.5(*."(+.&0*,&*&
"45.*$#.%& 5*.(& 4:& NOL<& *+& 49.84"(& =0#80& =*7& (c9#?*$(+.& .4& .0*.& 4:& .5*,#.#4+*$& 795A#8*$&
.0(5*/%2& b$48>& (.& *$2& G6O)OH& 0*?(& *$74& 5(8(+.$%& 5(/45.(,& #"/54?(,& WO& ,*%& *+,& $4+AB.(5"&
795?#?*$&=#.0& (+,4?*789$*5& 5(?*789$*5#7*.#4+&4:&.0(&-1J&84"/*5(,&.4&795A(5%&#+&/*.#(+.7&
#,(+.#:#(,&.0549A0&.0(&-=(,#70&[*789$*5&3(A#7.5%&:54"&)UUU&.4&6OOM<&*$.049A0&.0(&+((,&:45&
/547/(8.#?(&5*+,4"#7(,&,*.*&.4&84+:#5"&A549/&,#::(5(+8(7&=*7&0#A0$#A0.(,2&
V0(& A(+(5*$& ?#(=& .0*.& $*/*54.4"%& #7& 8598#*$& :45& *$$& /*.#(+.7& =#.0& J1E& .4& *77(77& #+.(7.#+*$&
?#*;#$#.%&*+,&/(5:45"&5(7(8.#4+&*7&5(c9#5(,&0*7&*$74&5(8(+.$%&;((+&c9(7.#4+(,2&J5.0957&(.&*$2&
G6O))H& 80*$$(+A(,& .0#7& /0#$474/0%& ;%& /(5:45"#+A& $*/*54.4"%& 4+$%& 4+& /*.#(+.7& =04& 0*,&
7#A+7&4:&/(5#.4+(*$&#+:$*""*.#4+&45&,(.(5#45*.(,&8$#+#8*$$%&:4$$4=#+A&#+#.#*$&5(?*789$*5#7*.#4+2&
I?(5& WOL& 4:& /*.#(+.7& #+& .0(& (+,4?*789$*5&.0(5*/%&A549/&,#,&+4.&9$.#"*.($%&5(c9#5(&
$*/*54.4"%<& .0(5(;%& *?4#,#+A& :95.0(5& /0%7#4$4A#8& #+79$.& .4& /*.#(+.7& =04& *5(& *$5(*,%&
85#.#8*$$%&#$$2&&&
J+4.0(5& #"/45.*+.& #779(& #7& .4& =0*.& (R.(+.& #780*("#*B5(/(5:97#4+& #+C95%& 4:& .0(& #+.(7.#+(<&
$(*,#+A&.4&"#854?*789$*5&#+C95%&*+,&8($$9$*5&+(8547#7&*+,&*/4/.47#7<&84+.5#;9.(7&.4&"45;#,#.%&
*+,&"45.*$#.%&#+&/*.#(+.7&#+&=04"&*5.(5#*$&5(?*789$*5#7*.#4+&#7&* *#+(,&*+,&=0(.0(5&?*5#497&
5(8(+.&*,?*+8(7& #+& /5(?(+.#+A& 45&$#"#.#+A&.0#7& /0(+4"(+4+& ,(785#;(,&#+& .0(& (R/(5#"(+.*$&
7#.9*.#4+&8*+&;(&.5*+7$*.(,&8$#+#8*$$%&G-*+.45*&(.&*$2<&6O))Y&D(.5*.&e&,(&`544.<&6O))Y&g$(77*7&(.&

*$2<&6O))H2&&
10. Conclusions
V0(5(&0*7&;((+&*&5(8(+.& /*5*,#A"&70#:.&#+&.0(&.5(*."(+.&4:& "(7(+.(5#8&#780*("#*2&S0(5(*7&
(+,4?*789$*5&.0(5*/%&=*7&4+8(&5(7(5?(,&:45&.0(&:(=&/*.#(+.7&=04&0*,&/540#;#.#?(&4/(5*.#?(&
5#7>7<&#.&#7&+4=&#+85(*7#+A$%&97(,&:45&5(?*789$*5#7*.#4+&4:&;4.0&8054+#8&*+,&*89.(&"(7(+.(5#8&
#780("#*2&!+,4?*789$*5&.0(5*/%& #7&$(77& #+?*7#?(& .0*+&4/(+&795A(5%<& *+,& #7&*7748#*.(,&=#.0&
$4=(5& /(5#B/548(,95*$& "45;#,#.%& *+,& "45.*$#.%2&V0(5(&#7&A54=#+A&(?#,(+8(&.0*.&7.(+.#+A&
"*%& *80#(?(& ;( (5& .(80+#8*$& 7988(77& *+,& /*.(+8%& 5*.(7& 84"/*5(,& =#.0& *+A#4/$*7.%& *$4+(2&
V0(& .#"#+A& *+,& 804#8(& 4:& #"*A#+A& "4,*$#.%& :45& 795?(#$$*+8(& 4:& ?(77($& /*.(+8%& 5("*#+7& *+&
#"/45.*+.& c9(7.#4+& :45& 8$#+#8#*+72& !::(8.#?(& *//54*80(7& .4& #"/54?#+A& $4+A(5B.(5"& ?(77($&
/*.(+8%&5*.(7&:4$$4=#+A&(+,4?*789$*5&.0(5*/%&*5(&5(c9#5(,<&*$4+A&=#.0&7.5*.(A#(7&.4&/5(?(+.&
#780*("#*B5(/(5:97#4+& #+C95%& #+& .047(& /*.#(+.7& =#.0& *89.(& "(7(+.(5#8& #780*("#*& #+& =04"&
5(?*789$*5#7*.#4+&#7&*80#(?(,2&

Percutaneous Angioplasty and Stenting for Mesenteric Ischaemia

7
11. References
J$"(#,*&iJ<&3#45,*+&-12&-/$(+#8&#+:*58.#4+&84"/$#8*.#+A&/(589.*+(497&.5*+7$9"#+*$&84($#*8&
*5.(5%& 7.(+.#+A& :45& 8054+#8& "(7(+.(5#8& #780*("#*2& Journal of Medical Case Reports&
6OOXY&6^&6M)2&
J5"7.54+A&DJ2&[#78(5*$&,9/$(R&78*++#+A^&(?*$9*.#4+&;(:45(&*+,&*:.(5&*5.(5%&#+.(5?(+.#4+&:45&
8054+#8&"(7(+.(5#8&#780("#*2&Perspect Vasc Surg Endovasc Ther&6OOKY&)U^&WXMBU62&
J5.0957&h1<&V#.97&i<&b*++*d*,(0&1<&(.&*$2&J&84"/*5#74+&4:&(+,4?*789$*5&5(?*789$*5#7*.#4+&
=#.0&.5*,#.#4+*$&.0(5*/%&:45&.0(&.5(*."(+.&4:&*89.(&"(7(+.(5#8&#780("#*. J Vasc Surg&
6O))Y&NW^MUXBKOP2&
J.>#+7& 1Q<& _=4$(>& Fi<& T*195*A$#*& `12& -95A#8*$& 5(?*789$*5#7*.#4+& ?(5797& (+,4?*789$*5&
.0(5*/%& :45& 8054+#8& "(7(+.(5#8& #780("#*^& *& 84"/*5*.#?(& (R/(5#(+8(2& J Vasc Surg&
6OOKY&PN^))M6B))K)2&
b$48>& VJ<& J847.*& -<& bC458>& 12& !+,4?*789$*5& *+,& 4/(+& 795A(5%& :45& *89.(& 488$97#4+& 4:& .0(&

79/(5#45&"(7(+.(5#8&*5.(5%2&i495+*$&4:&[*789$*5&-95A(5%&6O)OY&N6&GPH^&UNUBUMM2&
F*,("*5.#5#&g<&D*$9";4&J<& 1*::(#&!<&(.&*$2&Z4+#+?*7#?(&(?*$9*.#4+& 4:&.0(&8($#*8&.59+>&*+,&
79/(5#45&"(7(+.(5#8& *5.(5%&=#.0& "9$.#7$#8(&FV&#+&/*.#(+.7&=#.0&8054+#8&"(7(+.(5#8&
#780("#*2&Radiol Med&6OOXY&))W^))WNB))P62&
Q*$#5#& J2& `59+=*$,& F2& i4;7.& b<& (.& *$2& !+,4?*789$*5& .5(*."(+.& :45& 8054+#8& *.0(5478$(54.#8&
488$97#?(&"(7(+.(5#8&,#7(*7(^&#7&7.(+.#+A&79/(5#45&.4&;*$$44+&*+A#4/$*7.%j&Vasa&6O)OY&
WU^&W)UB6P&
g(+=#8>&iT<&S5#A0.2&!+,4?*789$*5&5(/*#5&4:&8054+#8&"(7(+.(5#8&488$97#?(&,#7(*7(^&.0(&54$(&4:&
,9/$(R&795?(#$$*+8(. Aust N Z J Surg&6OOKY&KK^MOBMW&
g$(77*7& EE<& D*/*$4#7& J!<& V49.49d*7& _<& h*A495#& g<& h4A5*:47& `F2& !::(8.7& 4:& $*d*54#,7& 4+&
#+.(7.#+*$& #780("#*& *+,& 5(/(5:97#4+& #+C95%& #+& (R/(5#"(+.*$& "4,($72& i495+*$& 4:&
-95A#8*$&3(7(*580&6O))Y&)MM^&6MNB6KP2&
g4$(%& 1E<& 14+(.*& `T<& J;49Bh*"d*"& J1& i5<& (.& *$2& 3(?*789$*5#7*.#4+& 4:& .0(& 79/(5#45&
"(7(+.(5#8&*5.(5%&*$4+(&:45&.5(*."(+.&4:&#+.(7.#+*$&#780("#*2&J Vasc Surg&6OOOYW6^WKB
PK&
`9/.*& D_<& '45*+& -1<& V95*A*& __<& 1#$$(5& Si<& D#/#+47& EE2& F054+#8& "(7(+.(5#8& #780("#*^&
(+,4?*789$*5& ?(5797& 4/(+& 5(?*789$*5#7*.#4+2& i495+*$& 4:& !+,4?*789$*5& V0(5*/%&
6O)OY&)K&GPH^&NPOBNPU2&
'*+7(+&_i<&S#$74+&Qb<&F5*?(+&V!<&(.&*$2&1(7(+.(5#8&*5.(5%&,#7(*7(&#+&.0(&($,(5$%2&J Vasc Surg&
6OOPYPO^PNBN6&
'45.4+& _1<& g#70"*+& !_2& 19$.#,(.(8.45& FV& *+A#4A5*/0%& #+& .0(& ,#*A+47#7& 4:& "(7(+.(5#8&
#780("#*2&Radiol Clin North Am&6OOKY&PN^6KNB6XX&
_*7#5*C*+&_<&Ik'*5*&Di<&`5*%&b'<&(.&*$2&F054+#8&"(7(+.(5#8&#780("#*^&I/(+&795A(5%&?(5797&
/(589.*+(497&*+A#4/$*7.%&*+,&7.(+.#+A2&J Vasc Surg 6OO)YWW^MWlK)&
_4$>"*+& ii<& 1(+7#+>& Db<& ?*+& D(.(57(+& J-<& (.& *$2& F$#+#8*$& *//54*80& .4& 8054+#8&
A*7.54#+.(7.#+*$& #780("#*& :54"& m#+.(7.#+*$& *+A#+*n& .4& .0(& 7/(8.59"& 4:& 8054+#8&
7/$*+80+#8&,#7(*7(2&Scand J Gastroenterol Suppl&6OOPY&6P)^&UB)M2&&
_49A#*7& D<& !$& -*%(,& '<& h049& S<& (.& *$2& 1*+*A("(+.& 4:& 8054+#8& "(7(+.(5#8& #780("#*2& V0(&
34$(&4:&!+,4?*789$*5&V0(5*/%2&J Endovasc Ther 6OOKY&)P^WUNBPON&
_49A#*7& D<& '9%+A& VV<& T#+& D'2& F$#+#8*$& 49.84"(7& 4:& "(7(+.(5#8& *5.(5%& 7.(+.#+A& ?(5797&

795A#8*$&5(?*789$*5#7*.#4+&#+&8054+#8&"(7(+.(5#8&#780("#*2&Int Angio.&6OOUY&6XG6H^)W6B
)WK2&&
Angioplasty, Various Techniques and Challenges in
Treatment of Congenital and Acquired Vascular Stenoses

8
T*#77%& iD<& V5#$$*9,& '<& Q49(>& D2& 13& *+A#4A5*/0%^& +4+#+?*7#?(& ?*789$*5& #"*A#+A& 4:& .0(&
*;,4"(+2&Abdom Imaging&6OO6Y&6K^PXXBNOM&
T*+,#7&1-<& 3*C*+& Q_<&-#"4+7& 1!<&(.&*$2&D(589.*+(497&"*+*A("(+.&4:&8054+#8&"(7(+.(5#8&
#780("#*^&49.84"(7&*:.(5&#+.(5?(+.#4+2&J Vasc Inter Radiol&6OONY&)M^)W)UB)W6N&
T4::54%&3<& (#+"(.d&!<&`9#9&b<&(.&*$2&34$(&:45&(+,4?*789$*5&.0(5*/%&#+&8054+#8&"(7(+.(5#8&
#780("#*2&Can J Gastroenterol&6OOUY&6W^WMNBWKW&
1*$A45&3Q<&I,(5#80&`-<&18_97#8>&1J<&1#75*&-<&_*$5*&1<&Q9+8*+&JJ<&b4=(5&VF<&`$*?#8d>#&
D2&3(79$.7&4:&7#+A$(B&*+,&.=4B?(77($&"(7(+.(5#8&*5.(5%&7.(+.7&:45&8054+#8&"(7(+.(5#8&
#780("#*2&J++*$7&4:&[*789$*5&-95A(5%&6O)OY&6P&GXH^&)OUPB))O)2&
1*.(4&3b<&Ik'*5*&Di<&'(5.d(5&Z3<&(.&*$2&!$(8.#?(&795A#8*$&.5(*."(+.&4:&7%"/.4"*.#8&8054+#8&
"(7(+.(5#8& 488$97#?(& ,#7(*7(^& (*5$%& 5(79$.7& *+,& $*.(& 49.84"(72& J Vasc Surg& )UUUY&
6U^X6)BW)&&
18J:((& 1_<& F0(55%& _i& i5<& Z*(77(+7& i1<& (.& *$2& E+:$9(+8(& 4:& 84"/$(.(& 5(?*789$*5#7*.#4+& 4+&
8054+#8&"(7(+.(5#8&#780("#*2&Am J Surg )UU6Y&)MP^66OBP&
181#$$*+& SQ<& 18F*5.0%& Si<& b5(7.#8>(5& 13<& (.&*$2&1(7(+.(5#8&*5.(5%&;%/*77^&4;C(8.#?(&
/*.(+8%&,(.(5"#+*.#4+2&J Vasc Surg&)UUNY&6)^&K6UBKPO&
14+(.*&`T<&T((&3S<&o(*A(5&3J<&(.&*$2&1(7(+.(5#8&,9/$(R&78*++#+A^&*&;$#+,(,&/547/(8.#?(&
7.9,%2&J Vasc Surg )UUWY&)K^KUBXP&
I (& iJ<& '9#7"*+& Jb<& `(($>(5>(+& 30<& (.& *$2& i(C9+*$& .4+4"(.5%& :45& .0(& ,#*A+47#7& 4:&
A*7.54#+.(7.#+*$& #780("#*2& g(*7#;#$#.%<& +45"*$& ?*$9(7& *+,& 84"/*5#74+& 4:& C(C(9+*$&
=#.0&A*7.5#8&.4+4"(.5%&(R(58#7(&.(7.#+A2&Eur J Gastroenterol Hepatol&6OOXY&6O^M6BMK&
D(8>& 1F<& F4+5*,& 1g<& _=4$(>& Fi<& (.& *$2& E+.(5"(,#*.(B.(5"& 49.84"(7& 4:& (+,4?*789$*5&
.5(*."(+.&:45&7%"/.4"*.#8&8054+#8&"(7(+.(5#8&#780("#*2&J Vasc Surg&6O)OY&N)^)POBK&
D(.5*.& g<& 34++& V<& ,(& `544.& '2D54.(8.#4+& ;%& /%59?*.(& #+:97#4+& #+& *& 5*.& "4,($& 4:& 7(?(5(&

#+.(7.#+*$& #780("#*B5(/(5:97#4+& #+C95%2& i495+*$& 4:& -95A#8*$& 3(7(*580& 6O))Y& )MK& G6H^&
(UWB()O)2&
-*+.45*& 3i<& T#(& 1T<& `5#A45(?& QZ<& Z*7#5& I<& 1445(& gJ<& '*7749+& 'V2& i495+*$& 4:& [*789$*5&
-95A(5%&6O)OY&N6&GPH^&)OOWB)O)P2&
-*5*8& VD<& J$.#+($& I<& _*70%*/& [<& (.& *$2& !+,4?*789$*5& .5(*."(+.& 4:& 7.(+4& .#8& *+,& 488$9,(,&
?#78(5*$&*5.(5#(7&:45&8054+#8&"(7(+.(5#8&#780("#*2&J Vasc Surg 6OOXY&PK^PXNBU)&
-80(5"(5045+&1T<&`#$(7&_J<&'*",*+&JQ<&(.&*$2&1(7(+.(5#8&5(?*789$*5#7*.#4+^&"*+*A("(+.&
*+,&49.84"(7&#+&.0(&@+#.(,& *.(7<&)UXXB6OOM2&J Vasc Surg 6OOUY&NO^WP)BWPX&
S#$74+&Qb<& 147.*:*?#& _<& F5*?(+&V!<& (.& *$2& F$#+#8*$&84957(& 4:& "(7(+.(5#8&*5.(5%& 7.(+47#7& #+&
($,(5$%&J"(5#8*+72&Arch Intern Med 6OOMY&)MM^6OUNB)OO2&&
h=4$*>& 31<& g#$$#+A(5& 1g<& S*$70& Qb<& (.& *$2& 1(7(+.(5#8& *+,& 8($#*8& ,9/$(R& 78*++#+A^& *&
?*$#,*.#4+&7.9,%2&i&[*78&-95A&)UUXY&6K^)OKXBXK2&
2
Cerebral Hyperperfusion
Syndrome After Angioplasty
!"#$%&'(%)
*
+#,"#-)./0%
*
+#,"#1/2/&32/4
5
+#,"#62%&/2%
5
+##
7"#8'(92%
:
+#;"#;%2.9&/<
=
#%&3#7"#>9?/&/<@>%9A%2
B

##
1
Department of Neurology
2
Department of Interventional Radiologist
3
Department of Neuroradiology
4
Department of Intensive Care
5
Department of Vascular Surgery
Hospital de Sabadell, Barcelona
Spain
1. Introduction
$/2/A2%0# CDE/2E/2F4)9'&# )D&32'?/# G$HIJ# K%)# F92).# 3/)L29A/3# AD# I4&3.# /.# %0"# G*MN*J# %)# %#
L09&9L%0# )D&32'?/# F'00'K9&O# L%2'.93# /&3%2./2/L.'?D# G$-7J# LC%2%L./29</3# AD# C/%3%LC/+#
&/42'0'O9L%0#3/F9L9.+#%&3#/E90/E.9L#)/9<42/)#.C%.#9)#&'.#L%4)/3#AD#L/2/A2%0#9)LC/?9%"###
PC9)#LC%E./2# 3/%0)# K9.C# .C9)# 4&L'??'&# A4.# &'.#/QL/E.9'&%0# L'?E09L%.9'&#'F# /&3'(%)L40%2#
.2/%.?/&.#'F#.C/#%2./29/)#.C%.#)4EE0D#.C/#A2%9&"#R/#4)/#.C/#./2?#L%2'.93#%2./2D#)./&.9&O#G$7IJ#
.'# 2/F/2# .'# )./&.9&O# 'F# .C/# 9&./2&%0# L%2'.93# %2./2D# GS$7J# A/L%4)/# ?').# E4A09L%.9'&)# %2/#
L/&./2/3# '&# .C9)# %2./2D"# ;'2/'(/2+# K/# 9&L043/# %&O9'E0%).D# K9.C'4.# )./&.# E0%L/?/&.# 9&# .C/#
./2?# $7I# .'# F%L909.%./# 2/%39&O# L'?E2/C/&)9'&# A/L%4)/# .C/# 2/0%.9'&# A/.K//&# /&3'(%)L40%2#
.2/%.?/&.#%&3#$HI#9)#2/0%./3#.'#2/(%)L40%29<%.9'&#9.)/0F#2%.C/2#.C%&#.'#)./&.#E0%L/?/&.#E/2#)/"##
>9(/&# .C/# C9OC# 2%./# 'F# 9)LC/?9L# A2%9&# 39)/%)/# 9&# 2/0%.9'&# .'# L%2'.93# )./&')9)# %&3# .C/# C9OC#
E2/(%0/&L/#'F#%)D?E.'?%.9L#L%2'.93#)./&')9)+#&4?/2'4)#E4A09L%.9'&)#39)L4))#$HI#9&#2/0%.9'&#
.'# $-7T# .C/# 9&L93/&L/# 9&# .C/)/# )/29/)# 2%&O/)# F2'?# U":V# .'# 5"5V"# H'K/(/2+# $7I# C%)#
L'&.9&4%00D#/('0(/3#9&#2/L/&.#D/%2)#.'#.C/#E'9&.#KC/2/+#%F./2#?'2/#.C%&#=U#D/%2)W#/QE/29/&L/+#
9.#9)#L'&)93/2/3#%&#%0./2&%.9(/#.'#$-7"#X42.C/2?'2/+#.C/#3/(/0'E?/&.#'F#&/K#?%./29%0)#F'2#
)./&.)+# F90./2)# F'2# 39).%0# E2'./L.9'&+# 34%0# %&.9E0%./0/.# .2/%.?/&.+# %&3# .C/# 0/%2&9&O# L42(/# %2/#
?9&9?9<9&O#.C/#)C'2.@#%&3#0'&O@./2?#%3(/2)/#/FF/L.)#'F#$7I"##

!'L4?/&./3#L'?E09L%.9'&)#'F#$7I#9&L043/#L/2/A2%0#/?A'09)?+#C/?'3D&%?9L#L'?E2'?9)/+#
(/))/0# 39))/L.9'&+# %&3# /%20D# 2/)./&')9)# %&3# 'LL04)9'&+# %)# K/00# %)# .C/# CDE/2E/2F4)9'&#
)D&32'?/#K/#3/%0#K9.C#9&#.C9)#LC%E./2"#;'2/'(/2+#.C/#)E/L.%L40%2#9&L2/%)/#9&#/&3'(%)L40%2#
.2/%.?/&.#C%)#2/(/%0/3#.C%.#CDE/2E/2F4)9'&#)D&32'?/#L%&#%0)'#'LL42#%F./2#2/(%)L40%29<%.9'&#
'F#'.C/2#%2./29/)+#)4LC#%)#.C/#(/2./A2%0#%2./29/)+#.C/#)4AL0%(9%&#%2./29/)+#'2#/(/&#.C')/#0'L%./3#
K9.C9&#.C/#A2%9&+#?%9&0D#.C/#?9330/#L/2/A2%0#%2./2D#G;$7J"##
S&#.C9)#LC%E./2#K/#K900#A/O9&#AD#39)L4))9&O#.C/#E%.C'ECD)9'0'OD+#L09&9L%0#E2/)/&.%.9'&+#%&3#
9&L93/&L/# 'F# $HI# 9&# .C/# 39FF/2/&.# E4A09)C/3# )/29/)"# R/# K900# .C/&# 39)L4))# .C/# 29)Y# F%L.'2)+#
39%O&').9L# ?/.C'3)+# %&3# ).2%./O9/)# F'2# E2/(/&.9'&# %&3# .2/%.?/&."# R/# K900# %0)'# 39)L4))# %#
Angioplasty, Various Techniques and Challenges in
Treatment of Congenital and Acquired Vascular Stenoses

10
L'&39.9'&#.C%.#)C%2/)#.C/#)%?/#E%.C'ECD)9'0'OD#%)#$HI+#L'&.2%).@9&34L/3#/&L/EC%0'E%.CD+#
9&# KC9LC# L'&.2%).# %O/&.)# L2'))9&O# .C/# A0''3@A2%9&# A%229/2# C%(/# %# .'Q9L# /FF/L.# '&# .C/# A2%9&#
E%2/&LCD?%+# 2/)40.9&O# 9&# )9O&)# %&3# )D?E.'?)# )9?90%2# .'# .C')/# 'F# $HI"# >9(/&# .C/# 0%2O/2#
&4?A/2# 'F# E4A09L%.9'&)# %A'4.# CDE/2E/2F4)9'&#%F./2#$-7#%&3#.C/#'A(9'4)#)9?90%29.9/)#9&#
%)E/L.)#09Y/#.C/#E%.C'ECD)9'0'OD#%&3#29)Y#F%L.'2)+#K/#2/F/2#.'#$-7#'&#&4?/2'4)#'LL%)9'&)#9&#
.C9)#LC%E./2"##
2. Pathophysiology
X92).+# K/# ?4).# 39FF/2/&.9%./# A/.K//&# .C/# L'&L/E.# 'F# CDE/2E/2F4)9'&# %&3# $HI"# S&# O/&/2%0+#
CDE/2E/2F4)9'&#9)#L'&)93/2/3#.'#'LL42#KC/&#L/2/A2%0#A0''3#F0'K#G$6XJ#9&#.C/#2/(%)L40%29</3#
./229.'2D# 9&L2/%)/)# AD# *UUV# '2# ?'2/# K9.C# 2/)E/L.# .'# .C/# A%)/09&/# (%04/)"# S&# )/29/)# AD#
ZO%)%K%2%#G5UU[J#%&3#X4Y43%#G5UU[J+#*\"[V#.'#5N"\V#'F#.C/#E%.9/&.)#K9.C#%&#9&L2/%)/#9&#$6X#
*UUV#3/(/0'E/3#$HI"#;'2/'(/2+#%#F/K#L%)/)#'F#$HI#9&#KC9LC#$6X#C%3#9&L2/%)/3#0/))#.C%&#
*UUV#C%(/#A//&#2/E'2./3#G]%2%E%&%D9'.93/)#/.#%0+#5UUB^#H/&3/2)'&#/.#%0+#5UU*J"#PC4)+#'.C/2#
F%L.'2)#?4).#A/#9&('0(/3#9&#$HI#GH')'3%#/.#%0+#5UU:^#]%Y4#/.#%0+#5UU=^#ZO%)%K%2%#/.#%0#5UU:^#
I4O%#/.#%0+#5UU[^#_')C9?'.'#/.#%0+#*MM[J"##
700#%4.C'2)#%O2//#.C%.#9.#9)#(/2D#09Y/0D#.C%.#.C/2/#C%)#.'#A/#3%?%O/#.'#L/2/A2%0#%4.'2/O40%.9'&+#
9&# '.C/2# K'23)+# 9?E%92/3# L/2/A2%0# (%)'2/%L.9(9.D# G$`8J+# F'2# $HI# .'# 'LL42# G]/4&/&# /.# %0+#

5UU*J"#
$/2/A2%0# C/?'3D&%?9L)# %&3# $`8# %2/# 9&39(934%09</3# 9&# /%LC# E%.9/&."# PC9)# L'403# A/#
/QE0%9&/3#AD#.C/#39FF/2/&.#/Q./&.#'F#L'00%./2%0#L92L40%.9'&#%(%90%A0/#%&3#AD#.C/#%4.'2/O40%.'2D#
?/LC%&9)?)#'F#.C/#L/2/A2%0#L92L40%.9'&"#PC/#E2/)/&L/#'F#)4FF9L9/&.#L'00%./2%0#L92L40%.9'&#C%)#%#
Y/D#2'0/#9&#.C/#E2/)/2(%.9'&#'F#$`8+#%&3#.C4)#E2'./L.)#%O%9&).#$HI"###
I9?90%20D+# '.C/2# 29)Y# F%L.'2)# F'2# $HI# %2/# 0'K# E40)%.909.D# 9&3/Q+# )/(/2/# 9E)90%./2%0# %&3#
L'&.2%0%./2%0#L%2'.93#39)/%)/+#%&3#%&#9&L'?E0/./#L92L0/#'F#R9009)#G,%&)/&#/.#%0+#*MM=^#8/9O/0#/.#
%0+#*MN[^#IA%29O9%#/.#%0#*MM:J"#
$`8#?%Y/)#9.#E'))9A0/#.'#Y//E#A0''3#E2/))42/#G61J#A/.K//&#%LL/E.%A0/#09?9.)#G\U#??HO#@#*\U#
??HOJ#.C2'4OC#%2./29'0%2#(%)'390%.%.9'&#'2#(%)'L'&).29L.9'&#9&#2/)E'&)/#.'#LC%&O/)#9&#L%2A'&#
39'Q93/"#PC9)#2/)E'&)/#9)#?').#E2'&'4&L/3#9&#)?%00/2#%2./29/)#G39%?/./2#UaBb*aU#??J+#KC/2/%)#
%2./29/)#K9.C#%#39%?/./2#'F#5aB#??#'2#?'2/#09Y/#.C/#S$7#)C'K#&'#)4A).%&.9%0#LC%&O/"##
8/O40%.9'&#9&('0(/)#%#?D'O/&9L#%&3#%#&/42'O/&9L#L'?E'&/&."#S&#?D'O/&9L#%4.'2/O40%.9'&+#
9&L2/%)/3# 9&.2%(%)L40%2# E2/))42/# 2/)40.)# 9&# (%)'L'&).29L.9'&# 'F# )?%00# %2./29'0/)# %.# C9OC#
)D)./?9L# 61+# A4.# KC/&# 61# /QL//3)# .C/# 09?9.# 'F# ?D'O/&9L# %4.'2/O40%.9'&+# .C/# 2/?%9&9&O#
%4.'2/O40%.9'&#9&#)?%00# %2./29/)#9)# 3/E/&3/&.#'&# )D?E%.C/.9L# %4.'&'?9L# 9&&/2(%.9'&"#7)# %#
2/)40.# 'F# )E%2)/# )D?E%.C/.9L# 9&&/2(%.9'&+# .C/# (/2./A2'A%)90%2# )D)./?# 9)# 0/))# E2'./L./3# .C%&#
'.C/2#2/O9'&)#'F#.C/#A2%9&+#KC9LC#/QE0%9&)#KCD#.C9)#)D)./?#9)#?'2/#%FF/L./3#9&#/&.9.9/)#09Y/#
CDE/2./&)9(/# /&L/EC%0'E%.CD"# S?E%92/3# $`8# 2/)40.)# 9&# F%9042/# 'F# .C/# %2./29%0# )D)./?# .'#
2/)E'&3#.'#%#)433/&#9&L2/%)/#9&#$6X#%&3#9)#4)4%00D#34/#.'#)/(/2/#(%)L40%2#)./&')9)#.'O/.C/2#
K9.C#9&)4FF9L9/&.#L'00%./2%0#A0''3#F0'K"#RC/&#.C/)/#.K'#F%L.'2)#L'/Q9).+#L/2/A2%0#E/2F4)9'&#9)#
?%9&.%9&/3#AD#.C/#?%Q9?4?#390%.9'&# 'F#.C/#%2./29'0/)"# PC9)#E2'0'&O/3#(%)'390%.9'&#?%Y/)#
.C/# (/))/0)# 4&%A0/# .'# 2/)E'&3# K9.C# (%)'L'&).29L.9'&# KC/&# A0''3# F0'K#9)#9&L2/%)/3+#%&3#
/)E/L9%00D#KC/&#9.#9)#9&L2/%)/3#)433/&0D#G7)LC/2#/.#%0+#5UU:^#,%&)/&#/.#%0+#*MM=^#8/9O/0#/.#%0+#
*MN[^#P%&O#/.#%0+#5UUN#IA%29O9%#/.#%0+#*MM:J"##
7.# .C/# /&3# 'F# .C/# *MMU)+# )'?/# )42O9L%0# 2/E'2.)# %02/%3D# )4OO/)./3# .C%.# E%.9/&.)# K9.C#
E2/'E/2%.9(/#C/?'3D&%?9L#F%9042/#K/2/#%.#3/F9&9./#29)Y#F'2#$HI#G6%Y/2#/.#%0+#*MMN^#$9Y29.#/.#
%0# *MM[^# _')C9?'.'# /.# %0+# *MM[J# %&3# .C%.# .C/# E2/)/&L/# 'F# %# L29.9L%0# )./&')9)# 9&# .C/# S$7#

Cerebral Hyperperfusion Syndrome After Angioplasty

11
9&L2/%)/3# .C/# 29)Y# 'F# 9&.2%L2%&9%0# C/?'22C%O/# GS$HJ# G,%&)/&# /.# %0+# *MM=^# ;%LF%20%&/# /.# %0+#
*MM*^# Z429/0# /.# %0+# *MMM^# IA%29O9%# /.# %0+# *MM:J"# 12/'E/2%.9(/# )9O&9F9L%&.# 2/34L.9'&# 9&# F0'K#
(/0'L9.D#L'?E%2/3#K9.C#A%)/09&/#(%04/)#9)#9&39L%.9(/#'F#CDE'E/2F4)9'&#%&3#9)#%))'L9%./3#K9.C#
E').'E/2%.9(/#CDE/2E/2F4)9'&#G]/4&/&#/.#%0+#5UU*J"#
I433/&#2/(%)L40%29<%.9'&#A2'4OC.#%A'4.#AD#%&O9'E0%).D#0/%3)#.'#3D)F4&L.9'&#'F#.C/#A0''3@
A2%9&# A%229/2# %F./2# .C/# F%9042/# 'F# %2./29'0%2# (%)'L'&).29L.9'&"# PC9)# 2/)40.)# 9&# .2%&)43%.9'&# 'F#
F0493#9&.'#.C/#E/29L%E900%2D#%).2'LD./)#%&3#9&./2).9.94?+#O9(9&O#29)/#.'#(%)'O/&9L#/3/?%"#PC9)#
CD32').%.9L# /3/?%# E2/3'?9&%&.0D# %FF/L.)# .C/# (/2./A2'A%)90%2# L92L40%.9'&# ./229.'2D# 9&# A'.C#
$HI#%&3#CDE/2./&)9(/#/&L/EC%0'E%.CD+#E'))9A0D#%)#%#2/)40.#'F#2/O9'&%0#(%29%.9'&#9&#L/2/A2%0#
)D?E%.C/.9L#9&&/2(%.9'&"#
PC/# ?').# /Q.2/?/# F'2?# 'F# .C9)# )D&32'?/# 9)# A0//39&O+# /9.C/2# S$H+# KC9LC# 2/)40.)# 9&# C9OC#
?'2A939.D#%&3#?'2.%09.D+#'2#)4A%2%LC&'93#C/?'22C%O/#GI7HJ+#KC9LC#C%)#%#A/ /2#E2'O&')9)"##
PC/# E%.C'ECD)9'0'OD# 'F# .C/# C/?'22C%O/# .C%.#2/)40.)#F2'?#2/(%)L40%29<%.9'&#?9OC.#A/#
39FF/2/&.#F2'?#.C%.#'F#$HI#3/)L29A/3#AD#I4&3.+#/.#%0#G*MN*J"#I'?/#%4.C'2)#G]%2%E%&%D9'.93/)#
/.# %0+# 5UUBJ# E2/F/2# .'# L%00# .C9)# /&.9.D# c2/E/2F4)9'&# )D&32'?/d# .'# /?EC%)9</# .C/# 3%?%O/# .'#
.9))4/)#L%4)/3#AD#)9?E0/#2/E/2F4)9'&"#I/(/2%0#9&(/).9O%.'2)#C%(/#%&%0D</3#.C/#LC%2%L./29).9L)#
'F#.C9)#S$H#KC/&#9.#%EE/%2)#9&#.C/#F92).#F/K#C'42)#%&3#K9.C'4.#E2'32'?/)+#% 29A4.9&O#9.#.'#
.C/# 24E.42/# 'F# 3//E# E/&/.2%.9&O# %2./29/)# %)# %# 2/)40.# 'F# .C/# )433/&# &'2?%09<%.9'&# 'F# .C/#
E2/))42/#'F#L/2/A2%0#E/2F4)9'&#%F./2#%&O9'E0%).D+#)9?90%2#.'#KC%.#'LL42)#9&#C/?'22C%O/#34/#
.'#CDE/2./&)9'&#G64CY#/.#%0+#5UU\^#$'4 )#/.#%0+#5UU:J"##
;%&D# L%)/)# 'F# I7H# %F./2# $7I# C%(/# A//&# 2/E'2./3# G7A'4@$C/A0# /.# %0+# 5UU=^# # $'4 )# /.# %0+#
5UU:^#H%2.?%&&#/.#%0+#5UU=^#H'#/.#%0+#5UUU^#;L$%A/#/.#%0+#*MMM^#;/D/2)#/.#%0+#5UUU^#;'229)C#/.#
%0+# 5UUU^# e9Y'0)YD# /.# %0+# 5UU5^# 190<# /.# %0+# 5UU\^# f42/)C9# /.# %0+# 5UU5J^# .C/)/# C%(/# %# A/ /2#
E2'O&')9)#.C%&#S$H"##
S.# 9)# 0'O9L%0# .'# %))4?/# .C%.# $6X# 9&L2/%)/)# )4A).%&.9%00D# %F./2# $7I# 9&# %# )/(/2/0D# )./&')/3#
L%2'.93# %2./2D"# H'K/(/2+# ).439/)# )C'K# .C%.# .C/# 9&L2/%)/# 9&# $6X# 9)# %L.4%00D# 2/0%./3# .'#
9?E%92/3# $`8"# S&# %# ).43D# AD# H')'3%# /.# %0# G*MMNJ# $6X# )9O&9F9L%&.0D# 9&L2/%)/3# '&# .C/# F92).#
E').'E/2%.9(/#3%D#9&#)4Ag/L.)#K9.C#2/34L/3#E2/'E/2%.9(/#$`8#A4.#&'.#9&#.C')/#K9.C#&'2?%0#

E2/'E/2%.9(/# $`8"# I9?90%20D+# 9&# %# ).43D# 'F# 5:# E%.9/&.)+# ]'# /.# %0# G5UUBJ# K/2/# 4&%A0/# .'#
3/?'&).2%./#%#2/0%.9'&#A/.K//&#.C/#3/O2//#'F#)./&')9)#%&3#.C/#9&L2/%)/#9&#$6X"#S&#)C'2.+#.C/#
3/O2//#'F#)./&')9)#L%&&'.#A/#L'&)93/2/3#%#Y/D#29)Y#F%L.'2#F'2#$HI+#%0.C'4OC#)'?/#)/29/)#C%(/#
.%Y/&#9.#9&.'#%LL'4&."##
7)LC/2# /.# %0# G5UU:J# ).439/3# =BB# E%.9/&.)# 4&3/2O'9&O# $-7# %&3# F'4&3# &'# 2/0%.9'&# A/.K//&#
$HI#%&3#.C/#)/(/29.D#'F#9E)90%./2%0#'2#L'&.2%0%./2%0#L%2'.93#)./&')9)+#%2./29%0#CDE/2./&)9'&+#'2#
E/29'E/2%.9(/# E/2F4)9'&# E2/))42/"# H'K/(/2+# ?/%&# S$7# ('04?/# F0'K# %&3# E/%Y# )D).'09L#
(/0'L9.D# ?/%)42/3# %.# .C/# '&)/.# 'F# )D?E.'?)# 9&# .C/# M# $HI# L%)/)# K/2/# C9OC/2# .C%&# 9&# .C/#
2/?%9&9&O#==\#L%)/)"#
S&#?').#L%)/)#'F# )D?E.'?%.9L# L%2'.93# )./&')/)#34/# .'# %# C/?'3D&%?9L# ?/LC%&9)?# $`8# 9)#
%0)'#3/F9L9/&.+#)'#9.#9)#0'O9L%0#.'#.C9&Y#.C%.#.C/D#K900#A/#?'2/#)4)L/E.9A0/#.'#3/(/0'E9&O#$HI#
%F./2#2/(%)L40%29<%.9'&#G62%&.0/D#/.#%0+#5UUMJ"#H'K/(/2+#9&#%#).43D#'F#:::#E%.9/&.)#4&3/2O'9&O#
$7I+# ]%2Y')# /.# %0# G5U*UJ# F'4&3# &'# )9O&9F9L%&.# 39FF/2/&L/)# A/.K//&# )D?E.'?%.9L# %&3#
%)D?E.'?%.9L#E%.9/&.)"##
X4Y43%# /.# %0# G5UU[J# L%229/3# '4.# %&# 9&./2/).9&O# ).43D# 'F# $6X# %&3# L/2/A2%0# A0''3# ('04?/#
G$6`J#9&#*B#E%.9/&.)#K9.C'4.#L'&.2%0%./2%0#L%2'.93#)./&')9)#4&3/2O'9&O#$-7"##PC/D#'A)/2(/3#
%# L'22/0%.9'&# A/.K//&# 9&L2/%)/3# $6`# %&3# 9&L2/%)/3# $6X# %F./2# $-7# '&# )9&O0/@EC'.'&#
/?9))9'&# L'?E4./3# .'?'O2%ECD# GI1-$PJ# %&3# ?%O&/.9L# 2/)'&%&L/# 9?%O9&O# G;8SJ+# K9.C#
)9O&)# 'F# CDE/2E/2F4)9'&# 9&# )/(/&# E%.9/&.)# G=[VJ"# PK'# 'F# .C/)/# )/(/&# E%.9/&.)# 3/(/0'E/3#
Angioplasty, Various Techniques and Challenges in
Treatment of Congenital and Acquired Vascular Stenoses

12
$HI+#KC/2/%)# &'&/#'F#.C/# /9OC.# E%.9/&.)#K9.C#&'2?%0#$6`#3/(/0'E/3#$HI"# S&# .C9)# ).43D+#
/0/(%./3# E2/'E/2%.9(/# $6`# K%)# .C/# '&0D# )9O&9F9L%&.# 9&3/E/&3/&.# E2/39L.'2# 'F# E').@$-7#
CDE/2E/2F4)9'&"###
PC/#/&3'.C/09%0#3%?%O/#L%4)/3# ?%9&0D# AD# LC2'&9L# CDE/2./&)9'&#9&#.C/#)?%00#%2./29/)#?%D#
%0)'#A/#2/0%./3#.'#L/2/A2%0#%4.'2/O40%.9'&#GIYD3/00#/.#%0+#*MN[J"#S&#F%L.+#)'?/#%4.C'2)#2/0%./#%#
C9).'2D#'F#).2'Y/#K9.C#%#O2/%./2#29)Y#'F#$HI#G$C%?'22'#/.#%0+#5UUU^#;L$%A/#/.#%0+#*MMMJ"##
7&'.C/2#9?E'2.%&.#A4.#&'.#/))/&.9%0#F%L.'2#%))'L9%./3#K9.C#$HI#9)#C9OC#A0''3#E2/))42/"#H9OC#

A0''3# E2/))42/# 9)# .C/# '&0D# F%L.'2# K/# L%&# .2/%.+# )'# 9.# C%)# A/L'?/# .C/# E29&L9E%0# .%2O/.# F'2#
E2/(/&.9'&# %&3# .2/%.?/&."# S&3//3+# .C/# E%.C'ECD)9'0'OD# 'F# $HI# 9)# )9?90%2# .'# .C%.# 'F#
CDE/2./&)9(/#/&L/EC%0'E%.CD#9&#KC9LC#.C/#A0''3@A2%9&#A%229/2#24E.42/)#%)#%#L'&)/h4/&L/#'F#
)/(/2/# CDE/2./&)9'&"# X42.C/2?'2/+# C9).'0'O9L# LC%&O/)# 09Y/# F9A29&'93# &/L2')9)# %&3# E/./LC9%0#
C/?'22C%O/#%0)'#'LL42#9&#A'.C#CDE/2./&)9(/#/&L/EC%0'E%.CD#%&3#$HI#G6/2&)./9&#/.#%0+#*MN=^#
;%&)''2#/.#%0+#*MM\^#ILCK%2.<#5UU5^#`%4OC%&#i#!/0%&.D+#5UUUJ"##
PC/# ?/LC%&9)?)# AD# KC9LC# 61# 9&L2/%)/)# %F./2# L%2'.93# 2/(%)L40%29<%.9'&# %2/# E''20D#
4&3/2).''3"#PC/#A%2'2/L/E.'2#2/F0/Q#?9OC.#A2/%Y#3'K&#%F./2#2/L/E.'2#3/&/2(%.9'&#%F./2#$-7#
'2# $7I+# %&3# CDE/2./&)9'&# %LL'?E%&D9&O# .C9)#F/%.42/#?9OC.#9&L2/%)/#L/2/A2%0#E/2F4)9'&#
KC9LC# 9)# ?'2/# /(93/&.# %F./2# A90%./2%0# L%2'.93# )42O/2D# G7C&# /.# %0+# *MNM^# 6'(/# /.# %0+# *M[M^#
P9??/2)#/.#%0+#5UU=J#%&3#9)#2/E'2./3#9&#*MV#.'#\=V#%F./2#$-7"##
PC/# ).9?40%.9'&# 'F# .C/)/# A%2'2/L/E.'2)# 9&# .C/# L%2'.93# A9F42L%.9'&# 3429&O# %&O9'E0%).D# L%&#
L%4)/# .2%&)9/&.# A2%3DL%239%# %&3# CDE'./&)9'&# # .C%.# L%&# A/# F'00'K/3# AD# 2/A'4&3#
CDE/2./&)9'&"# Z.C/2# EC/&'?/&%# E2'E')/3# .'# /QE0%9&# .C/# C9OC# A0''3# E2/))42/# 9&L043/#
9&L2/%)/3# &'2/E9&/EC29&/# 0/(/0)# E2'A%A0D# 2/0%./3# .'# L/2/A2%0# /3/?%# %&3# 9&L2/%)/3#
9&.2%L2%&9%0#E2/))42/+# .C/# 2/0/%)/# 'F# (%)'%L.9(/#&/42'E/E.93/)+#.C/#4)/#'F#%&/).C/.9L#324O)+#
%&3#E/29'E/2%.9(/#).2/))#G6%g%239#/.#%0+#*MNM^#6/&</0#i#H'EE/&)+#*MM*^#;%LF%20%&/#/.#%0+#*MM*^#
P'K&/#,6#i#6/2&C%23+#*MNU^#IYD3/00#/.#%0+#*MN[^#IY430%29LY#i#;''29&O+#*MN5^J"#
7&'.C/2#E'))9A0/#?/39%.'2#'F#9?E%92/3#%4.'2/O40%.9'&#9&#$HI#9)#&9.29L#'Q93/+#KC9LC#L%4)/)#
(%)'390%.%.9'&#%&3#L%&#9&L2/%)/# .C/#E/2?/%A909.D# 'F#L/2/A2%0# (/))/0)"#S&L2/%)/3# &9.29L#'Q93/#
0/(/0)# 3429&O# L0%?E9&O# 'F# .C/# S$7# %&3# 9&L2/%)/3# 'QDO/&@3/29(/3# F2//# 2%39L%0)# E2'34L/3#
3429&O# .C/# 2/).'2%.9'&# 'F# L/2/A2%0# E/2F4)9'&# %2/# 9&('0(/3# 9&# /&3'.C/09%0# 3D)F4&L.9'&# %&3#
3/./29'2%.9'&# 'F# %4.'2/O40%.'2D# ?/LC%&9)?)# %F./2# $-7# GI4O%# /.# %0+# 5UU[J"# I/(/2%0# %4.C'2)#
GZO%)%K%2%#/.# %0+# 5UU=^#I%9.'# /.#%0+# 5UU[J# C%(/#2/E'2./3# .C%.#.C/# 3/O2//# 'F#2/%L.9(/# 'QDO/&#
)E/L9/)#E2'34L.9'&#%F./2#9)LC/?9%#%&3#2/E/2F4)9'&#3429&O#$-7#3/E/&3)#'&#.C/#9&./&)9.D#'F#
L/2/A2%0#9)LC/?9%#3429&O#S$7#L0%?E9&O"##
8/%L.9(/# 'QDO/&# )E/L9/)# L%&# E0%D# %# 2'0/# 9&# .C/# E%.C'O/&/)9)# 'F# E').@$-7# CDE/2E/2F4)9'&+#
0/%39&O# .'# K93/)E2/%3# /&3'.C/09%0# 3%?%O/# 9&# .C/# 9E)90%./2%0# L/2/A2%0# %2./29/)# %&3# .C/2/AD#
9&L2/%)9&O#.C/#29)Y#'F#S$H#9&#.C/#/%20D#E').'E/2%.9(/#E/29'3"#X42.C/2?'2/+#%3?9&9)./29&O#%#
F2//@2%39L%0#)L%(/&O/2# L%&# E2/(/&.# $HI+# E2'(939&O# %339.9'&%0# )4EE'2.# F'2# .C9)# ?/LC%&9)?#

GZO%)%K%2%#/.#%0+#5UU=J"#
X9&%00D+#%&#%Q'&@09Y/#.29O/?9&'(%)L40%2#2/F0/Q#C%)#A//&#9?E09L%./3#9&#.C/#E%.C'ECD)9'0'OD#'F#
$HI# G;%LF%20%&/# /.# %0+# *MM*J"# PC/# 2/0/%)/# 'F# (%)'%L.9(/# &/42'E/E.93/)# F2'?# E/29(%)L40%2#
)/&)'2D#&/2(/)#(9%#%Q'&#2/F0/Q@09Y/#?/LC%&9)?)#C%)#%#)9O&9F9L%&.#A/%29&O#4E'&#%#&4?A/2#'F#
CDE/2E/2F4)9'&#)D&32'?/)"#
3. Clinical presentation
PC/#.DE9L%0#L09&9L%0#E2/)/&.%.9'&#'F#$HI#L'?A9&/)#)D?E.'?)#34/#.'#S$H#%&3#.C')/#34/#.'#
A2%9&#3%?%O/#L%4)/3#AD#(%)'O/&9L#/3/?%"#PC/#?').#L'??'&#)D?E.'?)#L%4)/3#AD#S$H#%2/#

Cerebral Hyperperfusion Syndrome After Angioplasty

13
C/%3%LC/+#L'&F4)9'&+#%0./2/3#0/(/0)#'F#L'&)L9'4)&/))+#%&3#)'?/.9?/)#('?9.9&O"#Z&#.C/#'.C/2#
C%&3+# .C/# /3/?%# 4)4%00D# ?%&9F/).)# %)# %# &/42'0'O9L%0# 3/F9L9.# '&# .C/# )93/# 'F# .C/# 4&.2/%./3#
L%2'.93# %2./2D+# 'F./&# %))'L9%./3# K9.C# /E90/E.9L# %L.9(9.D# G)/9<42/)+# 4)4%00D# ).%2.9&O# %)# E%2.9%0#
)/9<42/)J"# 72./29%0# CDE/2./&)9'&# 9)# .C/# &'2?# 9&# E%.9/&.)# .C%.# 3/(/0'E# )D?E.'?)# 'F# $HI^#
C'K/(/2+#9.#9)#9?E'2.%&.#.'#2/?/?A/2#.C%.#A2%3DL%239%#%&3#CDE'./&)9'&#'F./&#'LL42#9&9.9%00D#
%F./2#%&O9'E0%).D#34/#.'#).9?40%.9'&#'F#.C/#A%2'2/L/E.'2#2/F0/Q"##
RC/&# %# E%.9/&.# C%)# )D?E.'?)# 'F# &/42'0'O9L%0# 3/F9L9.#%F./2# %&O9'E0%).D+# .C/# F92).# 39%O&')9)#
L'&)93/2/3# 9)# /?A'09L# ).2'Y/# F2'?# L%2'.93# E0%h4/# A2'Y/&# 'FF# 3429&O#.C/#E2'L/342/"#PC4)+#
$HI# L%&# ?9?9L# %# ).2'Y/# '2# .2%&)9/&.# 9)LC/?9L# % %LY#GPS7J+# )'# 9.# 9)# 9?E'2.%&.# .'# .%Y/# 9&.'#
%LL'4&.#)D?E.'?)#09Y/#C/%3%LC/+#)/9<42/)+#%&3#%0./2/3#?/&.%0#).%.4)#.C%.#L%&#)4OO/).#$HI"#
e/(/2.C/0/))+# %L4./# &/42'0'O9L%0# 3/F9L9.# %LL'?E%&9/3# AD# C/%3%LC/# '2# /(/&# )/9<42/)# 9)#
'A(9'4)0D#L'?E%.9A0/#K9.C#S$H+#KC9LC#L%&#A/#240/3#'4.#'&0D#AD#&/42'9?%O9&O"##
e/42'0'O9L%0# 3/F9L9.# 34/# .'# (%)'O/&9L# /3/?%# 9)# 4)4%00D# .2%&)9.'2D+# O9(/&# .C/# %A)/&L/# 'F#
9)LC/?9L#9&F%2L.9'&#G6/2&)./9&#/.#%0+#*MN=^#19/EO2%)#/.#%0#*MNN^#8/9O/0#/.#%0+#*MN[^#I4&3.#/.#%0+#
*MN*^#I'0'?'&#/.#%0+#*MN\J"#70.C'4OC#.C/#&/42'0'O9L%0#)D?E.'?)#L%&#(%2D+#.C/#?').#L'??'&#
%2/# (9)4%0# '2# ?'.'2# 3/F9L9.)# %&3# %EC%)9%"# Z.C/2+# 2%2/2+# )D?E.'?)# 9&L043/# E)DLC'.9L#
%0./2%.9'&)#'2#?903#L'O&9.9(/#3/F9L9.#GZO%)%K%2%#/.#%0+#5UUBJ"#
I/9<42/)# %2/# O/&/2%00D# E%2.9%0# %.# F92).# %&3# )'?/.9?/)# A/L'?/# O/&/2%09</3# 0%./2+# %0.C'4OC#

O/&/2%09</3#)/9<42/)#L%&#%0)'#'LL42#9&9.9%00D#GH'#/.#%0+#5UUUJ^#9&#F%L.+#/(/&#).%.4)#/E90/E.9L4)#
C%)# A//&# 2/E'2./3# 4E# .'# .K'# K//Y)# %F./2# .C/# E2'L/342/# G]%Y4# /.# %0+# 5UU=J"# Z&/# .C923# 'F#
E%.9/&.)# K9.C# $HI# %F./2# $-7# C%(/# )/9<42/)#K9.C'4.#C/?9E%2/)9)+#%&'.C/2#.C923#C%(/#
C/?9E%2/)9)#K9.C'4.#)/9<42/)+#%&3#%&'.C/2#.C923#C%(/#A'.C#G6'429#/.#%0+#5U**J"##
$429'4)0D+# .C/# '&)/.# 'F# )D?E.'?)# %F./2# $-7# %&3# $7I# 39FF/2)"# ID?E.'?)# 4)4%00D# 3'# &'.#
%EE/%2#4&.90#.C2//#.'#)9Q#3%D)#%F./2#$-7"#S&#L'&.2%).+#)D?E.'?)#4)4%00D#%EE/%2#K9.C9&#%#F/K#
C'42)#'F#$7I"#ZO%)%K%2%#/.#%0#G5UU[J#2/E'2.#.C%.#.C/#9&L93/&L/#'F#$HI#E/%Y)#)9Q#3%D)#%F./2#
$-7#%&3#*5#C'42)#%F./2#$7I"#7F./2#2/(9/K9&O#:\#).439/)+#6'429#/.#%0#G5U**J#L'&L043/3#$HI#
E/%Y)#F9(/#3%D)#%F./2#$-7#%&3#.C/#0%./).#L%)/#'LL422/3#%F./2#5N#3%D)"##
PC/#)%?/#9)#.24/#'F#S$H+#KC9LC#%EE/%2)#*U"[#j#M"M#3%D)#%F./2#$-7#%&3#*"[#j#5"*#3%D)#%F./2#
$7I+# E/%Y9&O# 9&# .C/# F92).# *5# C'42)"# P%&# /.# %0#G5UU=J#).439/3#.C/#%EE/%2%&L/#%&3#'&)/.#'F#
L'?E09L%.9'&)#%F./2#$7I#9&# 5U*#E%.9/&.)^#.C/D#2/E'2.# *U#L%)/)# K9.C## PS7#G="MVJ+#B#'F# KC9LC#
'LL422/3#?'2/#.C%&#=N#C'42)#%F./2#.C/#E2'L/342/+#%&3#N#).2'Y/)#G:"MVJ+#B#'F#KC9LC#'LL422/3#
A/.K//&# 5# %&3# *M# 3%D)# %F./2# .C/# E2'L/342/"# $429'4)0D+# C'K/(/2+# .C/)/# %4.C'2)# F'4&3# &'#
L%)/)#'F#$HI"#
PC/# C/%3%LC/# 9&# $HI# 9)# 4)4%00D# ?'3/2%./# .'# )/(/2/# %&3# .C2'AA9&O+# )9?90%2# .'# %# ?9O2%9&/#
C/%3%LC/#G$'4 )#/.#%0+#5UU:J+#%&3#9.#4)4%00D#%FF/L.)#.C/#)%?/#)93/#%)#.C/#%2./2D#.2/%./3"##
H/%3%LC/#?%D#A/#.C/#'&0D#?%&9F/).%.9'&#'F#$HI#G$'&&'00D#5UUU^#Z429/0#/.#%0+#*MMM^#IA%29O9%#
/.# %0+# *MM:J+# )'# 'LL%)9'&%00D# 9.# C%)# A//&# L'&)93/2/3# %# 39%O&').9L# L29./29'&"# 7F./2# $-7+#
C/%3%LC/)#%2/#2/E'2./3#9&#5UV#'F#E%.9/&.)#K9.C'4.#$HI+#9&#BMV#'F#.C')/#K9.C#$HI+#%&3#9&#
N=V#'F#.C')/#K9.C#S$H#G6'429#/.#%0+#5U**J"#
1').E2'L/342%0#CDE/2./&)9'&#9)#%#L29.9L%0+#.C'4OC#&'.#/))/&.9%0+#F9&39&O#%))'L9%./3#K9.C#$HI#
GI'0'?'&#/.#%0+#*MN\^#ILC2'/3/2#/.#%0+#*MN[^#Z429/0#/.#%0#*MMMJ"#6'429#/.#%0#2/(9/K#G5U**J#F'4&3#
.C%.#.C/#?/%&#)D).'09L#61#'F#$HI#L%)/)#K%)#*NM#??HO#%.#E2/)/&.%.9'&+#%&3#.C/#E2'E'2.9'&#
'F# E%.9/&.)# K9.C# )/(/2/# CDE/2./&)9'&# K%)# )9O&9F9L%&.0D# C9OC/2# 9&# E%.9/&.)# KC'# 3/(/0'E/3#
$HI#%F./2#$-7#.C%&#9&#.C')/#KC'#393#&'."##
HDE'./&)9'&#'LL42)#9??/39%./0D#%F./2#$7I#9&#*MV#.'#B*V#'F#E%.9/&.)"#S.#9)#4)4%00D#.2%&)9/&.#
%&3# 2%2/0D# )D?E.'?%.9L+# %0.C'4OC# 9.# 0%).)# 0'&O/2# .C%&# 5=# C'42)# 9&# &/%20D# BV# 'F# E%.9/&.)"#
62%3DL%239%# 9)# %0)'# L'??'&+# K9.C# %&# 9&L93/&L/# 'F# :V# .'# :[V# 9&# E%.9/&.)# %3?9&9)./2/3#